Tablet's
| GENERIC NAME | COMPOSITION | SPEC. | QTY | UNIT |
|---|---|---|---|---|
| Fexofenadine & Montelukast Sodium Tablets | Each chewable tablet contains Fexofenadine Hydrochloride Montelukast Sodium eq. to Montelukast Excipients Approved colour used | IP IP | 120 10 | mg mg |
| Atorvastatin Tablets IP 10 mg | Atorvastatin Calcium Eq. to Atorvastatin Excipients Approved colour used | IP | 10 q.s | mg |
| Atorvastatin Tablets IP 20 mg | Atorvastatin Calcium Eq. to Atorvastatin Excipients Approved colour used | IP | 20 q.s | mg |
| Atorvastatin Tablets IP 40 mg | Each filmcoated tablet contains Atorvastatin Calcium Eq. to Atorvastatin Excipients Approved colour used | 40 q.s | mg | |
| Atorvastatin &Fenofibrate Tablets | Atorvastatin Calcium Eq. to Atorvastatin Fenofibrate Excipients Approved colour used | IP IP | 10 145 q.s | mg mg |
| Febuxostat Tablets 40 mg | Each film coated tablets contains Febuxostat Excipients Approved colour used | 40 q.s | mg | |
| Pantoprazole Sodium & Domperidone Tablets | Pantoprazole Sodium eq. to Pantoprazole Domperidone Each enteric coated tablets contains Excipients Approved colour used | IP IP | 20 10 q.s | mg mg |
| Ferrous Ascorbate, Folic Acid & Methylcobalamin Tablet | Each film coated tablet contains Ferrous ascorbate eq. to Elemental iron Folic acid Methylcobalamin Excipients Approved colour used | IP IP | 100 1.5 1500 q.s | mg mg mg |
| Ondansetron Tablets IP 4mg | Each uncoated orally disintegrating tablets contains Ondansetron hydrochloride Excipients Approved colour used | IP | 4 q.s | mg |
| Ondansetron Tablets IP 8 mg | Each uncoated orally disintegrating tablets contains Ondansetron hydrochloride Excipients Approved colour used | IP | 8 q.s | mg |
| Betahistine Dihydrochloride Tablets IP 8 mg | Each uncoated tablet contains: Betahistine Dihydrochloride excipients | IP | 8 q.s | mg |
| Acebrophylline, fexofenadine HCl & Montelukast Sodium Tablets | Each film coated tablet contains Acebrophylline Fexofenadine hydrochloride Montelukast sodium eq. to Montelukast Excipients Approved colour used | IP IP | 200 120 10 q.s | mg mg mg |
| Acebrophylline (SR) Tablets | Each film coated sustained release tablet contains Acebrophylline Excipients Approved colour used Each film coated tablet contains Aceclofenac Paracetamol | IP IP | 200 q.s 100 325 | mg mg mg |
| Aceclofenac, Paracetamol & Trypsin Chymotrypsin Tablets | Trypsin Chymotrypsin (50000 armour units of enzymatic activity supplied by a purified concentrate which has specific trypsin & chymotrypsin activity in a ratio of 6:1) excipients Approved colour used | BP | 50000 Q.S | A.U |
| Aceclofenac Tablets IP 100 mg | Each film coated tablet contains: Aceclofenac excipients Approved colour used | IP | Q.S | mg |
| Aceclofenac, Paracetamol and Chlorzoxazone tablets | Each film coated tablet contains: Aceclofenac Paracetamol Chlorzoxazone Approved colour used Excipients | IP IP USP | 100 325 500 Q.S | mg mg mg |
| Aceclofenac, Paracetamol and Thiocolchicoside tablets | Each film coated tablet contains: Aceclofenac Paracetamol Thiocolchicoside Excipients Approved colour used | IP IP IP | 100 325 4 Q.S | mg mg mg |
| Alfacalcidol, Calcium Carbonate eq.to Elemental Calcium tablets | Each film coated tablet contains: Alfacalcidol Calcium carbonate eq.to Elemental Calcium (from organic source oyster shell) Excipients Colour Titanium dioxide IP | BP IP | 0.25 200 Q.S | mg mg |
| Baclofen Tablets IP 10 mg | Each uncoated Tablet contains : Baclofen Excipients | IP | 10 Q.S | mg |
| Cilnidipine Tablets IP 10 mg | Each film coated tablet contains Cilnidipine Excipients Approved colour used | IP | 10 Q.S | mg |
| Cilnidipine Tablets IP 20 mg | Each film coated tablet contains Cilnidipine Excipients Approved colour used | IP | 20 Q.S | mg |
| Cilnidipine Tablets IP 5 mg | Each film coated tablet contains: Cilnidipine Excipients Approved colour used | IP | 5 Q.S | mg |
| Citicoline Tablet IP 500 mg | Each uncoated tablet contains: Citicoline Sodium eq.to Citicoline Excipients | IP | 500 Q.S | mg |
| Citicoline and Piracetam Tablets | Each film coated tablet contains: Citicoline Sodium eq.to Citicoline Piracetam Excipients Approved colour used | IP IP | 500 800 Q.S | mg mg |
| Clarithromycin Tablets IP 250 mg | Each film coated tablet contains: Clarithromycin Excipients Approved colour used | IP | 250 Q.S | mg |
| Clarithromycin Tablets IP 500 mg | Each film coated tablet contains: Clarithromycin Excipients Approved colour used | IP | 500 Q.S | mg |
| Desloratadine & Montelukast Sodium Tablets | Each film coated tablet contains: Desloratadine Montelukast sodium eq. to Montelukast Excipients Approved colour used | IP | 5 10 Q.S | mg mg |
| Desloratadine Tablet | Each film coated tablet contains: Desloratadine Excipients Approved colour used | IP | 5 Q.S | mg |
| Doxofylline & Ambroxol hydrochloride Tablets | Each film coated tablet contains: Doxofylline Ambroxol hydrochloride Excipients Approved colour used | IP IP | 400 30 Q.S | mg mg |
| Doxofylline Tablets IP 400 mg | Each uncoated tablet contains: Doxofylline Excipients | IP | 400 Q.S | mg |
| Etodolac Tablets IP 400 mg | Each film coated tablet contains Etodolac Excipients Approved colour used | IP | 400 Q.S | mg |
| Faropenem Sodium Tablets 200 mg | Each film coated tablet contains Faropenem Sodium Eq. to Faropenem Excipients Approved colour used | 200 Q.S | mg | |
| Faropenem Sodium Tablets 300 mg | Each extended release tablet contains Faropenem Sodium Eq. to Faropenem Excipients Approved Colour Used | 300 Q.S | mg | |
| Fluconazole Tablets IP 150 mg | Each uncoated tablet contains Fluconazole Excipients | IP | 150 Q.S | mg |
| Gabapentin & Nortriptyline Tablets | Each film coated tablet contains Gabapentin Nortriptyline HCl Eq. to Nortriptyline Excipients Approved Colour Used | USP IP | 400 10 Q.S | mg mg |
| Hydroxychloroquine Sulphate Tablets IP 200 mg | Each film coated tablet contains Hydroxychloroquine Sulphate Excipients Colour : Titanium Dioxide | IP | 200 Q.S | mg |
| Levosulpiride Tablets | Each uncoated tablet contains Levosulpiride Excipients | 25 Q.S | mg | |
| Montelukast Sodium Tablets IP | Each filmcoated tablet contains Montelukast Sodium Eq. to Montelukast Excipients Colour : Titanium Dioxide IP | IP | 10 Q.S | mg |
| Paracetamol , Phenylephrine HCl , Caffeine & Diphenhydramine HCl Tablets | Each uncoated tablet contains Paracetamol Phenylephrine HCl Caffeine Anhydrous Diphenhydramine HCl Excipients Colour: Approved Colour used | IP IP IP IP | 500 5 30 25 Q.S | mg mg mg mg |
| Paroxetine (CR) Tablets 12.5 mg | Paroxetine HCl Hemihydrate Eq. to Paroxetine Excipients Colour: Approved Colour used | B.P | 12.5 Q.S | mg |
| Paroxetine (CR) Tablets 25 mg | Each film coated control release tablet contains Paroxetine HCl Hemihydrate Eq. to Paroxetine Colour: Approved Colour used Excipients | B.p | 25 Q.S | mg |
| Pregabalin (SR) Tablets 75 mg | Each sustained release tablet contains Pregabalin Excipients Colour: Approved Colour used | IP | 75 Q.S | mg |
| Rifaximin Tablets 200 mg | Each film coated tablet contains Rifaximin Excipients Colour: Approved Colour used | BP | 200 Q.S | mg |
| Rifaximin Tablets 400 mg | Each film coated tablet contains Rifaximin Excipients Colour: Approved Colour used | BP | 400 Q.S | mg |
| Rosuvastatin & Fenofibrate Tablets | Each film coated tablet contains Rosuvastatin Calcium Eq. to Rosuvastatin Fenofibrate Excipients Colour: Approved Colour used | IP IP IP | 10 145 Q.S | mg mg |
| Rosuvastatin Tablets 20 mg | Each film coated tablet contains Rosuvastatin Calcium Eq. to Rosuvastatin Excipients Colour: Titanium Dioxide | IP IP | 20 Q.S | mg |
| Roxithromycin & Ambroxol Tablets | Each film coated tablet contains Roxithromycin Ambroxol HCl Excipients Colour: Approved Colour used | IP IP | 150 30 Q.S | mg mg |
| Roxithromycin Tablets IP 150 mg | Each film coated tablet contains Roxithromycin Excipients Colour: Titanium Dioxide | IP IP | 150 Q.S | mg |
| Telmisartan Tablets IP 40 mg | Each uncoated tablet contains : Telmisartan Excipients Colour: Approved Colour used | IP | 40 Q.S | mg |
| Telmisartan Tablets IP 80 mg | Each uncoated tablet contains : Telmisartan Excipients Colour: Approved Colour used | IP | 80 Q.S | mg |
| Telmisartan & Chlorthalidone Tablets | Each film coated tablet contains Telmisartan Chlorthalidone Excipients Approved Colour used in coating | IP IP | 40 12.5 Q.S | mg mg |
| Telmisartan & Hydrochlorothiazide Tablets | Each uncoated tablet contains Telmisartan Hydrochlorothiazide Excipients | IP IP | 40 12.5 Q.S | mg mg |
| Telmisartan & Cilnidipine Tablets | Each film coated tablet contains Telmisartan Cilnidipine Excipients Colour: Approved Colour used | IP | 40 10 Q..S | mg |
| Telmisartan & Amlodipine Tablets | Each uncoated tablet contains Telmisartan Amlodipine Besylate Eq. to Amlodipine Excipients | IP IP | 40 10 Q.S | mg mg |
| Teneligliptin Tablets | Each film coated tablet contains Teneligliptin Hydrobromide Hydrate Eq. to Teneligliptin Excipients Approved Colour used in coating | 20 Q.S | mg | |
| Teneligliptin & Metformin HCl (SR) Tablets | Each film coated tablet contains Teneligliptin Hydrobromide Hydrate Eq. to Teneligliptin Metformin HCl ( as sustained Release) Metformin HCl ( as sustained Release) Approved Colour used | IP | 20 500 Q.S | mg mg |
| Vildagliptin Tablets | Each uncoated tablet contains Vildagliptin Excipients | 50 Q.S | mg | |
| Vildagliptin & Metformin HCl Tablets | Each film coated tablet contains Vildagliptin Metformin HCl Excipients Approved Colour used | IP | 50 500 Q.S | mg |
| Vildagliptin & Metformin HCl Tablets | Each film coated tablet contains Vildagliptin Metformin HCl Excipients Approved Colour used | IP | 50 1000 Q.S | mg mg |
| Thiocolchicoside & Etoricoxib Tablets | Each film coated tablet contains Thiocolchicoside Etoricoxib Excipients Colour :Approved Colour used | IP IP | 4 60 Q.S | mg mg |
| Thiocolchicoside & Lornoxicam Tablets | Each film coated tablet contains Thiocolchicoside Lornoxicam Excipients Colour : Approved Colour used | IP IP | 4 8 Q.S | mg mg |
| Thiocolchicoside & Etoricoxib Tablets | Each film coated tablet contains Thiocolchicoside Etoricoxib Excipients Colour : Approved Colour used | IP IP | 8 60 Q.S | mg mg |
| Thiocolchicoside & Aceclofenac Tablets | Each film coated tablet contains Thiocolchicoside Aceclofenac Excipients Approved colour used | IP IP | 8 100 Q.S | mg |
| Torsemide Tablets IP 10 mg | Each uncoated tablet contains Torsemide Excipients | IP | 10 | mg |
| Torsemide Tablets IP 20 mg | Each uncoated tablet contains Torsemide Excipients | IP | 20 Q.S | mg |
| Torsemide & Spironolactone Tablets | Each uncoated tablet contains Torsemide Spironolactone Excipients | IP IP | 10 50 Q.S | mg mg |
| Torsemide & Spironolactone Tablets | Each film coated tablet contains Torsemide Spironolactone Approved Colour used Excipients | IP IP | 20 25 Q.S | mg mg |
| Trypsin Chymotrypsin, Diclofenac Potassium & Paracetamol Tablets | Each enteric coated tablet contains Trypsin Chymotrypsin (50000 armour units of enzymatic activity supplied by a purified concentrate which has specific trypsin & chymotrypsin activity in a ratio of 6:1) Diclofenac Potassium Paracetamol Excipients Approved Colour used | BP IP | 5000 50 325 Q.S | AU mg mg |
| Voglibose, Glimepiride & Metformin (SR) Tablets | Each uncoated tablet contains Voglibose Glimepiride Metformin Hydrochloride (SR) Excipients Approved colour used | IP IP IP | 0.2 2 500 Q.S | mg mg mg |
| Aceclofenac , Paracetamol & Chlorzoxazone Tablets | Each film coated tablet contains Aceclofenac Paracetamol Chlorzoxazone Excipients Colour :Approved colour used | IP IP USP | 100 325 250 Q.S | mg mg mg |
| Aceclofenac (SR) Tablets | Each film coated tablet contains Aceclofenac (As sustained Release) Excipients Colour :Approved colour used | IP | 200 Q.S | mg |
| Albendazole & Ivermectin Tablets | Each chewable tablets contains Albendazole Ivermectin Excipients Colour : Erythrosine | IP IP | 400 12 Q.S | mg mg |
| Amlodipine Tablets IP | Each uncoated tablets contains Amlodipine Besylate Eq. to Amlodipine Excipients | IP | 5 Q.S | mg |
| Amlodipine & Atenolol Tablets | Each uncoated tablets contains Amlodipine Besylate Eq. to Amlodipine Excipients Atenolol | IP IP | 5 50 Q.S | mg mg |
| Deflazacort Tablets | Each uncoated tablet contains Deflazacort Excipients | 30 Q.S | mg | |
| Diclofenac Potassium & Serratiopeptidase Tablets | Each enteric coated tablet contains Diclofenac Potassium Serrationpeptidase ( As enteric coated Granules eq. to Enzymatic activity 20,000 units) Excipients Colour: Approved colour used | BP IP | 50 10 Q.S | mg mg |
| Domperidone & Cinnarizine Tablets | Each uncoated tablet contains Domperidone Maleate Eq. to Domperidone Cinnarizine Excipients | IP IP | 15 20 Q.S | mg mg |
| Drotaverine & Aceclofenac Tablets | Each film coated tablet contains Drotaverine Hydrochloride Aceclofenac Excipients Colour:Approved colour used | IP | 80 100 Q.S | mg mg |
| Etoricoxib Tablets IP 90 mg | Each film coated tablet contains Etoricoxib Excipients Approved colour used | IP | 90 Q.S | mg |
| Etoricoxib Tablets IP 120 mg | Each film coated tablet contains Etoricoxib Excipients Approved colour used | IP | 120 Q.S | mg |
| Etoricoxib & Paracetamol Tablets | Each film coated tablet contains Etoricoxib Paracetamol Excipients Colour: Approved colour used | IP IP | 60 500 Q.S | mg mg |
| Fexofenadine Hydrochloride Tablets IP 180 mg | Each film coated tablet contains Fexofenadine Hydrochloride Excipients Colour: Approved colour used | IP | 180 Q.S | mg |
| Fexofenadine Hydrochloride Tablets IP 120 mg | Each film coated tablet contains Fexofenadine Hydrochloride Excipients Colour: Approved Colour used | IP | 120 Q.S | mg |
| Flupentixol & Melitracen Tablets | Each film coated tablet contains Flupentixol Dihydrochloride Eq.to Flupentixol Melitracen Hydrochloride Excipients Approved Colour used | BP | 0.5 10 Q.S | mg mg |
| Glimepiride & Metformin (SR) Tablets | Each uncoated tablet contains Glimepiride Metformin HCl (as sustained release form) Excipients Approved Colour used | IP IP | 1 500 Q.S | mg mg |
| Glimepiride & Metformin (SR) Tablets | Each uncoated tablet contains Glimepiride Metformin HCl (as sustained release form) Excipients | IP IP | 2 500 Q.S | mg mg |
| Glimepiride & Metformin (SR) Tablets | Each uncoated tablet contains Glimepiride Metformin HCl (as sustained release form) Excipients | IP IP | 3 500 Q.S | mg mg |
| Glimepiride & Metformin (SR) Tablets | Each uncoated tablet contains Glimepiride Metformin HCl (as sustained release form) Excipients Approved Colour used | IP IP | 4 500 Q.S | mg mg |
| Glimepiride Tablets IP 2 mg | Each uncoated tablet contains Glimepiride Excipients Approved Colour used | IP | 2 Q.S | mg |
| Glucosamine Sulphate Potassium Chloride , Methyl Sulphonyl Methane & Diacerein Tablets | Each film coated tablet contains Glucosamine Sulphate Potassium Chloride Methyl Sulphonyl Methane Diacerein Excipients Approved Colour used | USP USP IP | 750 250 50 Q.S | mg mg mg |
| Ilaprazole Tablets 10 mg | Each gastro resistant tablet contains Ilaprazole Excipients Approved Colour used | IP | 10 Q.S | mg |
| Levetiracetam Tablets IP 500 mg | Each film coated tablet contains Levetiracetam Excipients Colour Titanium dioxide | IP | 500 Q.S | mg |
| Levocetirizine Dihydrochloride Tablets IP 5 mg | Each film coated tablet contains Levocetirizine Dihydrochloride Excipients Colour Titanium dioxide | IP IP | 5 Q.S | mg |
| Levofloxacin Tablets IP 250 mg | Each film coated tablet contains Levofloxacin Hemihydrate Eq. to Levofloxacin Excipients Colour: Approved Colour used | IP | 250 Q.S | mg |
| Levofloxacin & Ornidazole Tablets | Each film coated tablet contains Levofloxacin Hemihydrate Eq. to Levofloxacin Ornidazole Excipients Approved Colour used | IP IP | 250 250 Q.S | mg mg |
| Lornoxicam Tablets 8 mg | Each film coated tablet contains Lornoxicam Excipients Approved Colour used | 8 Q.S | mg | |
| Lornoxicam & Paracetamol Tablets | Each filmcoated tablet contains Lornoxicam Paracetamol Excipients Approved Colour used | IP | 8 325 Q.S | mg mg |
| Methylcobalamin & Gabapentin Tablets | Each film coated tablet contains Methylcobalamin Gabapentin Excipients Approved Colour used | IP USP | 500 300 | mg mg |
| Metformin Hydrochloride Sustained Release Tablets IP 500 mg | Each uncoated sustained release tablet contains Metformin Hydrochloride (as sustained release form) Excipients Colour : Titanium Dioxide | IP IP | 500 Q.S | mg |
| Mefenamic acid & Paracetamol Tablets | Each film coated tablets contains Mefenamic Acid Paracetamol Excipients Approved Colour used | IP IP | 500 325 Q.S | mg mg |
| Metaxalone & Diclofenac Potassium Tablets | Each film coated tablets contains Metaxalone Diclofenac Potassium Excipients Colour : Titanium dioxide | IP BP | 400 50 Q.S | mg mg |
| Paracetamol Tablets IP 650 mg V | Each uncoated tablets contains Paracetamol Excipients | IP | 650 Q.S | mg |
| Acyclovir Tablets IP 800 mg | Each uncoated dispersible tablets contains Acyclovir Excipients | IP | 800 Q.S | mg |
| Allopurinol Tablets IP 300 mg | Each uncoated tablets contains Allopurinol Excipients | IP | 300 Q.S | mg |
| Allopurinol Tablets IP 100 mg | Each uncoated tablets contains Allopurinol Excipients | IP | 100 Q.S | mg |
| Betahistine Dihydrochloride Sustained Release Tablets IP 24 mg | Each uncoated sustained release tablet contains: Betahistine Dihydrochloride Excipients | IP | 24 Q.S | mg |
| Artemether & Lumefantrine Tablets | Each uncoated tablet contains: Artemether Lumefantrine Excipients Colour : Approved Colour used | IP | 80 480 Q.S | mg mg |
| Escitalopram Oxalate Tablets IP 10 mg | Each film coated tablet contains Escitalopram Oxalate Eq. to Escitalopram Excipients Colour : Approved Colour used | IP | 10 Q.S | mg |
| Escitalopram Oxalate Tablets IP 20 mg | Each film coated tablet contains Escitalopram Oxalate Eq. to Escitalopram Excipients Colour : Approved Colour used | IP | 20 Q.S | mg |
| Esomeprazole Tablets IP 40 mg | Each Delayed Release tablet contains Esomeprazole Magnesium Trihydrate Eq. to Esomeprazole Excipients Colour : Approved Colour used | IP | 40 Q.S | mg |
| Hydroxyzine Hydrochloride Sustained Release Tablets IP 25 mg | Each sustained release tablet contains Hydroxyzine Hydrochloride Excipients | IP | 25 Q.S | mg |
| Ivermectin Tablets 12 mg | Each uncoated dispersible tablet contains Ivermectin Excipients Colour : Sunset Yellow FCF | IP | 12 Q.S | mg |
| Losartan Potassium Tablets IP 50 mg | Each film coated tablet contains Losartan Potassium Excipients Colour : Approved Colour used | IP | 50 Q.S | mg |
| Losartan Potassium & Hydrochlorothiazide Tablets IP | Each film coated tablet contains Losartan Potassium Hydrochlorothiazide Excipients Colour : Approved Colour used | IP IP | 50 12.5 Q.S | mg mg |
| Metoprolol Succinate Extended Release Tablets IP 50 mg | Each Exteneded release tablet contains Metoprolol Succinate Excipients Colour : Approved Colour used | IP | 50 Q.S | mg |
| Metoprolol Succinate Prolonged Release Tablets IP 25 MG | Each Prolonged Release tablet contains Metoprolol Succinate Excipients Approved colour used | IP | 25 Q.S | mg |
| Mirtazapine Tablets IP 15 mg | Each film coated tablet contains Mirtazapine Excipients Colour Titanium dioxide | IP | 15 Q.S | mg |
| Moxifloxacin Tablets 400 mg | Each film coated tablet contains Moxifloxacin Hydrochloride Eq. to Moxifloxacin Excipients Approved Colour used | IP | 400 Q.S | mg |
| Olanzapine Mouth Dissolving Tablets IP 10 mg | Each uncoated mouth dissolving tablets contains Olanzapine Excipients | IP | 10 Q.S | mg |
| Olanzapine Mouth Dissolving Tablets IP 5 mg | Each uncoated mouth dissolving tablet contains Olanzapine Excipients | IP | 5 Q.S | mg |
| Olmesartan Medoxomil Tablets IP 20 mg | Each film coated tablet contains Olmesartan Medoxomil Excipients Colour : Titanium Dioxide | IP IP | 20 Q.S | mg |
| Olmesartan Medoxomil & Hydrochlorthiazide Tablets IP | Each film coated tablets contains Olmesartan Medoxomil Hydrochlorthiazide Excipients Colour : Titanium Dioxide | IP IP IP | 20 12.5 Q.S | mg mg |
| Olmesartan Medoxomil Tablets IP 40 mg | Each film coated tablets contains Olmesartan Medoxomil Excipients Colour : Approved Colour used | IP | 40 Q.S | mg |
| Olmesartan Medoxomil & Hydrochlorthiazide Tablets IP | Each film coated tablets contains Olmesartan Medoxomil Hydrochlorthiazide Excipients Colour : Titanium Dioxide | IP IP IP | 40 12.5 Q.S | mg mg |
| Rabeprazole Sodium Tablets IP 20 mg | Each enteric coated tablets contains Rabeprazole Sodium Excipients Colour: Approved Colour used | IP | 20 Q.S | mg |
| Rabeprazole Sodium & Domperidone Tablets | Each enteric coated tablets contains Rabeprazole Sodium Domperidone Excipients Colour: Approved Colour used | IP IP | 20 10 Q.S | mg mg |
| Rifaximin Tablets 550 mg | Each film coated tablet contains Rifaximin Excipients Colour: Approved Colour used | BP | 550 Q.S | mg |
| Sertraline Tablets IP 50 mg | Each uncoated tablet contains Sertraline Hydrochloride Eq. to Sertraline Excipients | IP | 50 Q.S | mg |
| Tamsulosin Hydrochloride & Dutasteride Tablets | Each film coated tablet contains Tamsulosin Hydrochloride (as modified release) Dutasteride Excipients Colour: Approved Colour used | IP IP | 0.4 0.5 Q.S | mg mg |
| Losartan Potassium & Amlodipine Tablets | Each uncoated tablet contains Losartan Potassium Amlodipine Besylate Eq. to Amlodipine Excipients | IP IP | 50 5 Q.S | mg mg |
| Vildagliptin & Metformin HCl Tablets | Each film coated tablet contains Vildagliptin Metformin HCl Excipients Approved Colour used | IP | 50 850 Q.S | mg mg |
| Calcium Carbonate & Vitamin D3 Tablets IP | Each film coated tablet contains Calcium Carbonate Eq.to Elemental Calcium Vitamin D3 Excipients Approved Colour used | IP IP | 250 500 Q.S | mg mg |
| Calcium Citrate Maleate, Magnesium Hydroxide , Zinc Sulphate Monohydrate & Vitamin D3 Tablets | Each film coated tablet contains Calcium Citrate Maleate Magnesium Hydroxide Eq.to Elemental Magnesium Zinc Sulphate Monohydrate eq. to Elemental Zinc Vitamin D3 Excipients Approved Colour used | USP IP IP IP | 1000 1004 200 Q.S | mg mg L.U |
| Vitamin D3 Tablets IP | Each chewable tablet contains Vitamin D3 (Cholecalciferol) Excipients Approved Colour used | IP | 6000 Q.S | L.U |
| Rosuvastatin & Fenofibrate Tablets | Each filmcoated tablet contains Rosuvastatin Calcium Eq. to Rosuvastatin Fenofibrate Excipients Colour: Approved Colour used | IP IP | 20 160 Q.S | mg mg |
| Doxophylline & Montelukast Sodium Tablets | Each uncoated sustained release tablet contains Doxophylline (as sustained release) Montelukast Sodium eq. to Montelukast Excipients Approved colour used | IP IP | 400 10 Q.S | mg mg |
| Clopidogrel Tablets I.P 75 mg | Each film coated tablet contains Clopidogrel Bisulphate Eq. to Clopidogrel Excipients Approved Colour used | IP | 75 Q.S | mg |
| Clopidogrel & Aspirin Tablets | Each film coated tablet contains Clopidogrel Bisulphate Eq. to Clopidogrel Aspirin Excipients Approved Colour used | IP IP | 75 75 Q.S | mg mg |
| Clopidogrel & Aspirin Tablets | Each film coated tablet contains Clopidogrel Bisulphate IP Eq. to Clopidogrel Aspirin Excipients Approved Colour used | IP IP | 75 150 Q.S | mg mg |
| Citicoline and Piracetam Tablets | Each film coated tablet contains: Citicoline Sodium eq.to Citicoline Piracetam Excipients Approved colour used | IP IP | 500 400 Q.S | mg mg |
| Cefpodoxime & Ofloxacin Tablets | Each film coated tablet contains Cefpodoxime Proxetil Eq. to Cefpodoxime Ofloxacin Excipients Approved colour used | IP IP | 200 200 Q.S | mg mg |
| Cefpodoxime & Dicloxacillin (ER) Tablets | Each film coated tablet contains Cefpodoxime Proxetil Eq. to Cefpodoxime Dicloxacillin Sodium Eq. to Dicloxacillin (as extended release) Excipients Approved colour used | IP IP | 200 500 Q.S | mg mg |
| Cefixime Trihydrate, Cloxacillin Sodium (ER) & Lactic Acid Tablets | Each film coated tablet contains Cefixime Trihydrate Eq. to anhydrous Cefixime Cloxacillin Sodium Eq. to Cloxacillin (as extended release) Lactic Acid Bacillus Excipients Approved colour used | IP IP | 200 500 90 Q.S | mg mg mg Million Spores |
| Cefixime And Dicloxacillin Extended Release Tablets | Each film coated tablet contains Cefixime Trihydrate Eq. to Anhydrous Cefixime Dicloxacillin Sodium Eq. to Dicloxacillin (as extended release) Excipients Approved colour used | IP IP | 200 500 Q.S | mg mg |
| Cefdinir Tablets 300 mg | Each film coated tablet contains Cefdinir Excipients Approved Colour used | USP | 300 Q.S | mg |
| Carbamazepine Sustained Release Tablets 200 mg | Each Sustained Release tablet contains Carbamazepine (As sustained release) Excipients | IP | 200 Q.S | mg |
| Atorvastatin & Telmisartan Tablets | Each film coated tablet contains Atorvastatin Calcium Eq. to Atorvastatin Telmisartan Excipients Approved colour used | IP IP | 10 40 Q.S | mg mg |
| Atorvastatin & Amlodipine Tablets | Each film coated tablet contains Atorvastatin Calcium Eq. to Atorvastatin Amlodipine Besylate Eq. to Amlodipine Excipients Approved colour used | IP IP | 10 5 Q.S | mg mg |
| Acyclovir Tablets IP 400 mg | Each uncoated dispersible tablet contains Acyclovir Excipients | IP | 400 Q.S | mg |
| Amisulpride Tablets IP 50 mg | Each uncoated tablet contains Amisulpride Excipients | IP | 50 Q.S | mg |
| Amisulpride Tablets IP 100 mg | Each uncoated tablet contains Amisulpride Excipients | IP | 100 Q.S | mg |
| Amisulpride Tablets IP 200 mg | Each uncoated tablet contains Amisulpride Excipients | IP | 200 Q.S | mg |
| Amlodipine, Olmesartan Medoxomil, Hydrochlorothiazide Tablets | Each film coated tablet contains Amlodipine Besylate Eq. to Amlodipine Olmesartan Medoxomil Hydrochlorthiazide Excipients Approved colour used | IP IP IP | 10 40 25 Q.S | mg mg mg |
| Amlodipine & Telmisartan Tablets | Each uncoated tablet contains Amlodipine Besylate Eq. to Amlodipine Telmisartan Excipients | IP IP | 10 40 Q.S | mg mg |
| Amlodipine & Telmisartan Tablets | Each uncoated tablet contains Amlodipine Besylate Eq. to Amlodipine Telmisartan Excipients | IP IP | 10 80 Q.S | mg mg |
| Amlodipine, Telmisartan & Hydrochlorothiazide Tablets | Each uncoated tablet contains Amlodipine Besylate Eq. to Amlodipine Telmisartan Hydrochlorothiazide Excipients | IP IP IP | 10 80 25 Q.S | mg mg mg |
| Amlodipine, Telmisartan & Hydrochlorothiazide Tablets | Each uncoated tablet contains Amlodipine Besylate Eq. to Amlodipine Telmisartan Hydrochlorothiazide Excipients | IP IP IP | 5 40 12.5 Q.S | mg mg mg |
| Clopidogrel & Aspirin Tablets | Each film coated tablet contains Clopidogrel Bisulphate Eq. to Clopidogrel Aspirin Excipients Approved Colour used | IP IP | 300 150 Q.S | mg mg |
| Acarbose Tablets IP 50 mg | Each uncoated tablet contains Acarbose Excipients | IP | 50 Q.S | mg |
| Sparfloxacin Tablets 200 mg | Each film coated tablet contains Sparfloxacin Excipients Colour : Approved Colour used | 200 Q.S | mg | |
| Carvedilol Tablets IP 6.25 mg | Each uncoated tablet contains Carvedilol Excipients Approved Colour used | IP | 6.25 Q.S | mg |
| Carvedilol Tablets IP 3.125 mg | Each uncoated tablet contains Carvedilol Excipients Approved Colour used | IP | 3.125 Q.S | mg |
| Chlorthalidone Tablets IP 6.25 mg | Each uncoated tablet contains Chlorthalidone Excipients | IP | 6.25 Q.S | mg |
| Ebastine Tablets IP 20 mg | Each film coated tablet contains Ebastine Excipients Approved Colour used | IP | 20 Q.S | mg |
| Vitamin K2-7, Calcium Carbonate & Vitamin D3 Tablets | Each film coated tablet contains Vitamin K2-7 Calcium Carbonate Eq.to Elemental Calcium Vitamin D3 Excipients Approved Colour used | IP | 50 500 500 Q.S | mcg mg IU |
| Biotin Tablets 10 mg | Each film coated tablet contains Biotin Approved Colour used Excipients | BP | 10 Q.S | mg |
| Voriconazole Tablets IP 200 mg | Each film coated tablet contains Voriconazole Excipients Approved Colour used | IP | 200 Q.S | mg |
| Finasteride Tablets IP 5 mg | Each film coated tablet contains Finasteride Excipients Approved Colour Used | IP | 5 Q.S | mg |
| Fluconazole Tablets IP 400 mg | Each uncoated tablet contains Fluconazole Excipients | IP | 400 Q.S | mg |
| Thyroxine Sodium Tablets IP 50 mcg | Each uncoated tablet contains Thyroxine Sodium Excipients | IP | 50 Q.S | mg |
| Olopatadine Hydrochloride Tablets 5 mg | Each film coated tablet contains Olopatadine Hydrochloride Excipients Approved Colour Used | USP | 5 Q.S | mg |
| Norfloxacin & Tinidazole Tablets | Each film coated tablet contains Norfloxacin Tinidazole Excipients Approved Colour Used | IP IP | 400 600 Q.S | mg mg |
| Nebivolol Hydrochloride & Telmisartan Tablets | Each uncoated tablet contains Nebivolol Hydrochloride Eq. to Nebivolol Telmisartan Excipients | IP IP | 5 40 Q.S | mg mg |
| Metformin (SR) & Pioglitazone Tablets | Each uncoated tablet contains Metformin HCl (as sustained release form) Pioglitazone Hydrochloride Eq. to Pioglitazone Excipients | IP IP | 500 15 Q.S | mg mg |
| Loratadine Tablets 10 mg | Each uncoated tablet contains Loratadine Excipients | BP | 10 Q.S | mg |
| Labetalol Hydrochloride Tablets IP 100 mg | Each uncoated tablet contains Labetalol Hydrochloride Excipients | 100 Q.S | mg | |
| Hydroxyzine Hydrochloride Tablets IP 10 mg | Each film coated tablet contains Hydroxyzine Hydrochloride Excipients Approved Colour Used | IP | 10 Q.S | mg |
| Ofloxacin & Nitazoxanide Tablets | Each film coated tablet contains Ofloxacin Nitazoxanide Excipients Approved Colour Used | IP | 200 500 Q.S | mg mg |
| Olanzapine , Fluoxetine Hydrochloride Tablets | Each film coated tablet contains Olanzapine Fluoxetine Hydrochloride Excipients Approved Colour Used | IP USP | 10 20 Q.S | mg mg |
| Olanzapine Tablets IP 15 mg | Each film coated tablet contains Olanzapine Excipients | IP | 15 Q.S | mg |
| Olanzapine Tablets IP 7.5 mg | Each film coated tablet contains Olanzapine Excipients | IP | 7.5 Q.S | mg |
| Amlodipine & Olmesartan Medoxomil Tablets | Each film coated tablet contains Amlodipine Besylate Eq. to Amlodipine Olmesartan Medoxomil Approved colour used Excipients | IP IP | 5 20 Q.S | mg mg |
| Metoprolol Succinate (ER) & Olmesartan Medoxomil Tablets | Each film coated tablet contains Metoprolol Succinate Eq. to Metoprolol Tartrate (As extended release form) Olmesartan Medoxomil Excipients Approved colour used | IP IP | 50 20 Q.S | mg mg |
| Olmesartan & Chlorthalidone Tablets | Each film coated tablet contains Chlorthalidone Olmesartan Medoxomil Excipients Approved colour used | IP IP | 12.5 20 Q.S | mg mg |
| Olmesartan & Chlorthalidone Tablets | Each film coated tablet contains Chlorthalidone Olmesartan Medoxomil Excipients Approved colour used | IP IP | 12.5 40 Q.S | mg mg |
| Olmesartan Medoxomil & Ramipril Tablets | Each film coated tablet contains Olmesartan Medoxomil Ramipril Excipients Approved Colour used | IP IP | 40 5 Q.S | mg mg |
| Olopatadine Hydrochloride & Ambroxol (SR) Tablets | Each film coated tablet contains Olopatadine Hydrochloride Ambroxol Hydrochloride Eq. to Ambroxol (as sustained release) Excipients Approved Colour Used | USP IP | 5 30 Q.S | mg mg |
| Ornidazole Tablets IP 500 mg | Each film coated tablet contains Ornidazole Excipients Colour : Tartrazine | IP | 500 Q.S | mg |
| Oxcarbazepine Tablets 150 mg | Each film coated tablet contains Oxcarbazepine Excipients Approved colour used | IP | 150 Q.S | mg |
| Oxcarbazepine Tablets 300 mg | Each film coated tablet contains Oxcarbazepine Excipients Approved colour used | IP | 300 Q.S | mg |
| Oxcarbazepine Tablets 450 mg | Each sustained release tablet contains Oxcarbazepine Excipients Approved colour used | IP | 450 Q.S | mg |
| Pantoprazole Gastro Resistant Tablets IP 20 mg | Each gastro resistant tablet contains Pantoprazole Sodium Eq. to Pantoprazole Excipients Approved colour used | IP | 20 Q.S | mg |
| Pentoxifylline Extended Release Tablets 400 mg | Each uncoated tablet contains Pentoxifylline (as extended release) Excipients | B.P | 400 Q.S | mg |
| Paroxetine Tablets 10 mg | Each film coated tablet contains Paroxetine HCl Hemihydrate Eq. to Paroxetine Excipients Colour: Sunset Yellow FCF | B.P | 10 Q.S | mg |
| Paroxetine Tablets 20 mg | Each film coated tablet contains Paroxetine HCl Hemihydrate Eq. to Paroxetine Excipients Colour: Sunset Yellow FCF | B.P | 20 Q.S | mg |
| Paroxetine Tablets 30 mg | Each film coated tablet contains Paroxetine HCl Hemihydrate Eq. to Paroxetine Excipients Colour: Sunset Yellow FCF | B.P | 30 Q.S | mg |
| Paroxetine Tablets 40 mg | Each film coated tablet contains Paroxetine HCl Hemihydrate Eq. to Paroxetine Excipients Colour: Sunset Yellow FCF | B.P | 40 Q.S | mg |
| Piroxicam & Paracetamol Tablets | Each film coated tablet contains Piroxicam Paracetamol Excipients Colour: Sunset Yellow FCF | IP IP | 20 500 Q.S. | mg mg |
| Ranolazine Extended Release Tablets 500 mg | Each Extended release tablet contains Ranolazine(As extended release) Excipients | 500 Q.S. | mg | |
| Pregabalin (SR) Tablets 150 mg | Each uncoated sustained release tablet contains Pregabalin Excipients | IP | 150 Q.S. | mg |
| Pregabalin (SR) Tablets 300 mg | Each uncoated sustained release tablet contains Pregabalin Excipients Colour: Approved Colour used | IP | 300 Q.S. | mg |
| Pregabalin (SR) & Methylcobalamin Tablets | Each uncoated tablet contains Pregabalin (as sustained release) Methylcobalamin Excipients | IP IP | 75 1500 Q.S. | mg mg |
| Propranolol Hydrochloride Tablets IP 20 mg | Each uncoated tablet contains Propranolol Hydrochloride Excipients | IP | 20 Q.S. | mg |
| Propranolol (SR) & Flunarizine Tablets | Each uncoated tablet contains Propranolol Hydrochloride(as sustained release) Flunarizine Dihydrochloride Excipients | IP BP | 40 10 Q.S. | mg mg |
| Quetiapine Tablets IP 25 mg | Each film coated tablet contains Quetiapine Fumarate Eq. to Quetiapine Excipients Colour : Yellow oxide of iron & Titanium dioxide | IP | 25 Q.S. | mg |
| Quetiapine Tablets IP 50 mg | Each film coated tablet contains Quetiapine Fumarate Eq. to Quetiapine Excipients Colour : Yellow oxide of iron & Titanium dioxide | IP | 50 Q.S. | mg |
| Quetiapine Tablets IP 100 mg | Each film coated tablet contains Quetiapine Fumarate Eq. to Quetiapine Excipients Colour : Yellow oxide of iron & Titanium dioxide | IP | 100 Q.S. | mg |
| Ramipril Tablets IP 2.5 mg | Each uncoated tablet contains Ramipril Excipients | IP | 2.5 Q.S. | mg |
| Ramipril Tablets IP 5 mg | Each uncoated tablet contains Ramipril Excipients | IP | 5 Q.S. | mg |
| Ramipril Tablets IP 10 mg | Each uncoated tablet contains Ramipril Excipients | IP | 10 Q.S. | mg |
| Ramipril & Hydrochlorothiazide Tablets IP | Each uncoated tablet contains Ramipril Hydrochlorothiazide Excipients | IP IP | 2.5 12.5 Q.S. | mg mg |
| Ramipril & Telmisartan Tablets | Each uncoated tablet contains Telmisartan Ramipril Excipients | IP IP | 40 2.5 Q.S | mg mg |
| Ramipril & Telmisartan Tablets | Each uncoated tablet contains Telmisartan Ramipril Excipients | IP IP | 40 5 Q.S | mg mg |
| Ranitidine Hydrochloride Tablets I.P 150 mg | Each film coated tablet contains Ranitidine Hydrochloride Eq. to Ranitidine Excipients Approved Colour Used | IP | 150 Q.S. | mg |
| Ranitidine Hydrochloride Tablets I.P 300 mg | Each film coated tablet contains Ranitidine Hydrochloride Eq. to Ranitidine Excipients Approved Colour Used | IP | 300 Q.S. | mg |
| Risperidone & Trihexyphenidyl Hydrochloride Tablets | Each uncoated tablet contains Risperidone Trihexyphenidyl Hydrochloride Excipients | BP IP | 2 2 Q.S. | mg mg |
| Risperidone & Trihexyphenidyl Hydrochloride Tablets | Each uncoated tablet contains Risperidone Trihexyphenidyl Hydrochloride Excipients | BP IP | 3 2 Q.S. | mg mg |
| Risperidone & Trihexyphenidyl Hydrochloride Tablets | Each uncoated tablet contains Risperidone Trihexyphenidyl Hydrochloride Excipients | BP IP | 4 2 Q.S. | mg mg |
| Risperidone Tablets 1 mg | Each film coated tablet contains Risperidone Excipients Colour :Titanium dioxide | BP | 1 Q.S. | mg |
| Risperidone Tablets 2 mg | Each film coated tablet contains Risperidone Excipients Colour :Titanium dioxide | BP | 2 Q.S. | mg |
| Risperidone Tablets 3 mg | Each film coated tablet contains Risperidone Excipients Colour :Titanium dioxide | BP | 3 Q.S. | mg |
| Risperidone Tablets 4 mg | Each film coated tablet contains Risperidone Excipients Colour :Titanium dioxide | BP | 4 Q.S. | mg |
| Rosuvastatin Tablets IP 5 mg | Each film coated tablet contains Rosuvastatin Calcium Eq. to Rosuvastatin Excipients Colour :Approved colour used | IP | 5 Q.S. | mg |
| Rosuvastatin Tablets IP 40 mg | Each film coated tablet contains Rosuvastatin Calcium Eq. to Rosuvastatin Excipients Colour: Approved Colour used | IP IP | 40 Q.S. | mg |
| Roxithromycin Tablets IP 300 mg | Each film coated tablet contains Roxithromycin Excipients Colour: Approved Colour used | IP | 300 Q.S. | mg |
| Satranidazole & Ofloxacin Tablets | Each film coated tablet contains Satranidazole Ofloxacin Excipients Colour: Approved Colour used | IP | 300 200 Q.S. | mg mg |
| Sertraline Hydrochloride Tablets 100 mg | Each film coated tablet contains Sertraline Hydrochloride Eq. to Sertraline Excipients Colour :Approved colour used | BP | 100 Q.S. | mg |
| Sildenafil Citrate Tablets 50 mg | Each film coated tablet contains Sildenafil Citrate Eq. to Sildenafil Excipients Colour : Indigo caramine | 50 Q.S. | mg | |
| Sitagliptin Phosphate Tablets IP 50 mg | Each film coated tablet contains Sitagliptin Phosphate Monohydrate Eq. to Sitagliptin Excipients Colour : Titanium Dioxide | IP | 50 Q.S. | mg |
| Sitagliptin Phosphate Tablets IP 100 mg | Each film coated tablet contains Sitagliptin Phosphate Monohydrate Eq. to Sitagliptin Excipients Colour : Approved Colour used | IP | 100 Q.S. | mg |
| Sodium Feredetate, Folic Acid, Vit B12 & Zinc Sulphate Tablets | Each Film coated tablet contains Sodium Feredetate Eq. to Elemental Iron 33 mg Folic Acid Vit B12 Zinc Sulphate Monohydrate Eq. to Elemental Zinc Excipients Approved Colour used | BP IP IP IP | 231 1.5 15 11 Q.S. | mg mg mg mg |
| Sodium Feredetate, Folic Acid, Vit B12 Tablets | Each Film coated tablet contains Sodium Feredetate Eq. to Elemental Iron 33 mg Folic Acid Vit B12 Excipients Approved Colour used | BP IP IP IP | 231 1.5 15 Q.S | mg mg mg |
| Sultamicillin Tablets | Each Film coated tablet contains Sultamicillin (as Tosylate) Eq. to Sulbactum 147 mg & Ampicillin 220 mg Excipients Colour: Titanium Dioxide | PI IP | 375 Q.S. | mg |
| Tadalafil Tablets 10 mg | Each Film coated tablet contains Tadalafil Excipients Colour : Yellow Oxide of Iron | IP | 10 Q.S. | mg |
| Tadalafil Tablets 20 mg | Each Film coated tablet contains Tadalafil Excipients Colour : Yellow Oxide of Iron | IP | 20 Q.S. | mg |
| Telmisartan Tablets IP 20 mg | Each uncoated tablet contains Telmisartan Excipients Colour: Approved Colour used | IP | 20 Q.S. | mg |
| Amlodipine, Telmisartan & Hydrochlorothiazide Tablets | Each uncoated tablet contains Amlodipine Besylate Eq. to Amlodipine Telmisartan Hydrochlorothiazide Excipients | IP IP IP | 2.5 20 6.25 Q.S. | mg mg mg |
| Terbinafine Tablets IP 250 mg | Each uncoated tablet contains Terbinafine Hydrochloride Eq. to Terbinafine Excipients | IP | 250 Q.S. | mg |
| Theophylline Prolonged Release Tablets 400 mg | Each prolonged Release uncoated tablet contains Theophylline Anhydrous (As prolonged release) Eq. to Theophylline Excipients | IP | 400 Q.S. | mg |
| Theophylline (SR) & Montelukast Tablets | Each uncoated tablet contains Theophylline Anhydrous (As sustained release) Eq. to Theophylline Montelukast Sodium Eq. to Montelukast Excipients | IP IP | 400 10 Q.S. | mg |
| Thiocolchicoside Tablets 4 mg | Each uncoated tablet contains Thiocolchicoside Excipients | IP | 4 Q.S. | mg |
| Thyroxine Sodium Tablets IP 12.5 mcg | Each uncoated tablet contains Thyroxine Sodium Excipients | IP | 12.5 Q.S. | mg |
| Thyroxine Sodium Tablets IP 25 mcg | Each uncoated tablet contains Thyroxine Sodium Excipients | IP | 25 Q.S. | mg |
| Thyroxine Sodium Tablets IP 75 mcg | Each uncoated tablet contains Thyroxine Sodium Excipients | IP | 75 Q.S. | mg |
| Thyroxine Sodium Tablets IP 100 mcg | Each uncoated tablet contains Thyroxine Sodium Excipients | IP | 100 Q.S. | mg |
| Tizanidine Hydrochloride & Aceclofenac Tablets | Each Film coated tablet contains Tizanidine Hydrochloride Eq. to Tizanidine Aceclofenac Excipients Approved Colour used | IP IP | 2 100 Q.S. | mg mg |
| Tofisopam Tablets 50 mg | Each uncoated tablet contains Tofisopam Excipients | JP | 50 Q.S. | mg |
| Tofisopam Tablets 100 mg | Each uncoated tablet contains Tofisopam Excipients | JP | 100 Q.S. | mg |
| Tolperison Hydrochloride & Diclofenac Sodium Tablets | Each film coated tablet contains Tolperison Hydrochloride Diclofenac Sodium Excipients Colour: Titanium Dioxide | JP IP IP | 150 50 Q.S. | mg mg |
| Tolperison Hydrochloride & Paracetamol Tablets | Each film coated tablet contains Tolperison Hydrochloride Paracetamol Excipients Colour: Titanium Dioxide | JP IP IP | 150 500 Q.S. | mg mg |
| Tolperison Tablets 150 mg | Each film coated tablet contains Tolperison Hydrochloride Excipients Colour: Titanium Dioxide | JP IP | 150 Q.S. | mg |
| Tolperison Sustained Release Tablets 450 mg | Each sustained release tablet contains Tolperison Hydrochloride Excipients Colour: Titanium Dioxide | JP IP | 450 Q.S. | mg |
| Tolperison Hydrochloride & Etodolac Tablets | Each uncoated tablet contains Tolperison Hydrochloride Etodolac Excipients Colour: Red Oxide of Iron | JP IP | 150 400 Q.S. | mg mg |
| Venlafaxine Hydrochloride Tablets 37.5 mg | Each uncoated tablet contains Venlafaxine Hydrochloride Excipients | BP | 37.5 Q.S. | mg |
| Venlafaxine Hydrochloride Tablets 75 mg | Each uncoated tablet contains Venlafaxine Hydrochloride Excipients | BP | 75 Q.S. | mg |
| Voglibose Tablets | Each uncoated tablet contains Voglibose Excipients | IP | 0.2 Q.S. | mg |
| Voglibose Tablets | Each uncoated tablet contains Voglibose Excipients | IP | 0.3 Q.S. | mg |
| Vitamin C Chewable Tablet | Each uncoated chewable tablet contains Ascorbic Acid Sodium Ascorbate eq. to Ascorbic Acid ExcipientsColour: Sunset Yellow FCF | IP IP | 100 450 400 Q.S. | mg mg mg |
| Telmisartan & Metprolol Succinate (ER) Tablets | Each uncoated tablet contains Telmisartan Metoprolol Succinate Eq. to Metoprolol Tartrate (As extended Release) Excipients Colour : Red oxide of Iron | IP IP | 40 50 Q.S. | mg mg |
| Telmisartan & Metprolol Succinate (ER) Tablets | Each uncoated tablet contains Telmisartan Metoprolol Succinate Eq. to Metoprolol Tartrate (As extended Release) Excipients Colour : Red oxide of Iron | IP IP | 20 25 Q.S. | mg mg |
| Teneligliptin & Metformin Hydrochloride (SR) Tablets | Each uncoated tablet contains Teneligliptin Hydrobromide Hydrate Eq. to Teneligliptin Metformin Hydrochloride (as Sustained Release) Excipients Approved Colour used | IP | 20 1000 Q.S. | mg mg |
| Ketoprofen & Thiocolchicoside Tablets | Each film coated tablet contains Ketoprofen Thiocolchicoside Excipients Approved Colour used | IP IP | 50 4 Q.S. | mg mg |
| Ebastine Tablets IP 10 mg | Each film coated tablet contains Ebastine Excipients Approved Colour used | IP | 10 Q.S. | mg |
| Labetalol Hydrochloride Tablets IP 50 mg | Each film coated tablet contains Labetalol Hydrochloride Excipients Colour : Sunset Yellow FCF | IP | 50 Q.S. | mg |
| Enalapril Maleate Tablets IP 10 mg | Each uncoated tablet contains Enalapril Maleate Excipients | IP | 10 Q.S. | mg |
| Enalapril Maleate & Hydrochlorothiazide Tablets | Each uncoated tablet contains Enalapril Maleate Hydrochlorothiazide Excipients | IP IP | 10 25 Q.S. | mg mg |
| Etoricoxib Tablets IP 60 mg | Each film coated tablet contains Etoricoxib Excipients Approved colour used | IP | 60 Q.S. | mg |
| Faropenem Sodium Tablets 450 mg | Each extended release tablet contains Faropenem Sodium Eq. to Faropenem Excipients Colour Titanium Dioxide | IP | 450 Q.S. | mg |
| Methylcobalamin & Gabapentin Tablets | Each film coated tablet contains Methylcobalamin Gabapentin Excipients Approved Colour used | IP USP | 500 100 Q.S. | mg mg |
| Gabapentin Extended Release Tablets 600 mg | Each film coated extended release tablet contains Gabapentin (As extended Release) Excipients Approved | IP | 600 Q.S. | mg |
| Glimepiride & Pioglitazone Hydrochloride Tablets | Each film coated tablet contains Glimepiride Pioglitazone Hydrochloride eq. to Pioglitazone Excipients Approved Colour used | IP IP | 1 15 Q.S. | mg mg |
| Labetalol Hydrochloride Tablets IP 200 mg | Each film coated tablet contains Labetalol Hydrochloride Excipients Colour : Sunset Yellow FCF | IP | 200 Q.S. | mg |
| Levofloxacin & Ambroxol Hydrochloride (SR) Tablets | Each film coated tablet contains Levofloxacin Hemihydrate Eq. to Levofloxacin Ambroxol hydrochloride (As sustained Release) Excipients Approved Colour used | IP IP | 250 75 Q.S. | mg mg |
| Levofloxacin & Ambroxol Hydrochloride (SR) Tablets | Each film coated tablet contains Levofloxacin Hemihydrate Eq. to Levofloxacin Ambroxol hydrochloride (As sustained Release) Excipients Approved Colour used | IP IP | 500 75 Q.S. | mg mg |
| Levosulpiride Tablets 50 mg | Each uncoated tablet contains Levosulpiride Excipients | IP | 50 Q.S. | mg |
| Levosulpiride Tablets 100 mg | Each uncoated tablet contains Levosulpiride Excipients | IP | 100 Q.S. | mg |
| Linagliptin & Metformin Tablets | Each film coated tablet contains Linagliptin Metformin Hydrochloride Excipients Approved colour used | IP | 2.5 500 Q.S. | mg mg |
| Linagliptin & Metformin Tablets | Each film coated tablet contains Linagliptin Metformin Hydrochloride Excipients Approved colour used | IP | 2.5 1000 Q.S. | mg mg |
| Losartan Potassium & Chlorthalidone Tablets | Each film coated tablet contains Losartan Potassium Chlorthalidone Excipients Colour Titanium dioxide | IP IP | 50 12.5 Q.S. | mg mg |
| Losartan Potassium & Atenolol Tablets | Each film coated tablet contains Losartan Potassium Atenolol Excipients Colour : Titanium dioxide | IP IP | 50 50 Q.S. | mg mg |
| Losartan Potassium & Chlorthalidone Tablets | Each film coated tablet contains Losartan Potassium Chlorthalidone Excipients Colour Titanium dioxide | IP IP | 25 6.25 Q.S. | mg mg |
| Mesalazine Prolonged Release Tablets | Each prolonged release film coated tablet contains Mesalazine (As prolonged release) Excipients Approved Colour used | IP | 1200 Q.S. | mg |
| Metformin (ER) & Pioglitazone Tablets | Each uncoated tablet contains Metformin HCl (as Extended Release form) Pioglitazone Hydrochloride Eq. to Pioglitazone Excipients | IP IP | 500 30 Q.S. | mg mg |
| Methylprednisolone Tablets 16 mg | Each uncoated tablet contains Methylprednisolone Excipients | IP | 16 Q.S. | mg |
| Metoprolol Succinate (ER) & Hydrochlorothiazide Tablets | Each uncoated tablet contains Metoprolol Succinate (As extended Release) Hydrochlorothiazide Excipients Approved colour used | IP IP | 50 12.5 Q.S. | mg mg |
| Metoprolol Succinate (ER) & Hydrochlorothiazide Tablets | Each uncoated tablet contains Metoprolol Succinate (As extended Release) Hydrochlorothiazide Excipients Approved colour used | IP IP | 25 12.5 Q.S. | mg mg |
| Metoprolol Succinate (ER) & Olmesartan Medoxomil Tablets | Each film coated tablet contains Metoprolol Succinate (As extended Release) Olmesartan Medoxomil Excipients Approved colour used | IP IP | 25 20 Q.S. | mg mg |
| Metoprolol Succinate (ER) & Olmesartan Medoxomil Tablets | Each film coated tablet contains Metoprolol Succinate (As extended Release) Olmesartan Medoxomil Excipients | IP IP | 50 20 Q.S. | mg mg |
| Mirtazapine Tablets IP 30 mg | Each film coated tablet contains Mirtazapine Excipients Colour Titanium dioxide | IP | 30 Q.S. | mg |
| Nebivolol Hydrochloride & Hydrochlorothiazide Tablets | Each Uncoated tablet contains Nebivolol Hydrochloride Eq. to Nebivolol Hydrochlorothiazide Excipients | IP IP | 5 12.5 Q.S. | mg mg |
| Nebivolol Hydrochloride Tablets IP 5 mg | Each uncoated tablet contains Nebivolol Hydrochloride Eq. to Nebivolol Excipients | IP | 5 Q.S. | mg |
| Nitrofurantoin Tablets IP 50 mg | Each film coated tablet contains Nitrofurantoin Excipients Approved colour used | IP | 50 Q.S. | mg |
| Nitrofurantoin Tablets IP 100 mg | Each film coated tablet contains Nitrofurantoin Excipients Approved colour used | IP | 100 Q.S. | mg |
| Acebrophylline & Acetylcysteine Tablets | Each film coated tablet contains Acebrophylline Acetylcysteine Excipients Approved Colour used | BP | 100 600 Q.S. | mg mg |
| Amlodipine, Telmisartan & Chlorthalidone Tablets | Each uncoated tablet contains Amlodipine Besylate Eq. to Amlodipine Telmisartan Chlorthalidone Excipients Approved colour used | IP IP IP | 5 40 12.5 Q.S. | mg mg mg |
| Methylcobalamin,L- Methylfolate Calcium & Pyridoxal 5-Phosphate Tablets | Each film coated tablet contains Methylcobalamin L- Methylfolate Calcium Pyridoxal 5-Phosphate Excipients Approved colour used | IP USP USP | 1500 1 0.5 Q.S. | mg mg mg |
| Isoxsuprine Hydrochloride Sustained Release Tablets | Each film coated sustained release tablet contains : Isoxsuprine Hydrochloride Excipients Excipients | IP | 40 Q.S. | mg |
| Ebastine & Montelukast Sodium Tablets | Each film coated tablet contains Ebastine Montelukast Sodium Eq. to Montelukast Excipients Approved Colour used | IP IP | 10 10 Q.S. | mg mg |
| Aceclofenac, Paracetamol, Phenylephrine Hydrochloride, Cetirizine Hydrochloride & Caffeine Tablets | Each uncoated tablet contains : Aceclofenac Paracetamol Phenylephrine Hydrochloride Cetirizine Hydrochloride Caffeine (Anhydrous) Excipients | IP IP IP IP IP | 100 325 5 10 25 Q.S. | mg mg mg mg mg |
| Sevelamer Carbonate Tablets 400 mg | Each film coated tablet contains Sevelamer Carbonate Excipients Colour : Approved Colour used | 400 Q.S. | mg | |
| Sevelamer Carbonate Tablets 800 mg | Each film coated tablet contains Sevelamer Carbonate Excipients Colour : Approved Colour used | 800 Q.S. | mg | |
| Rabeprazole Gastro Resistant Tablets 40 mg | Each Gastro Resistant tablet contains Rabeprazole Sodium Excipients Colour: Titanium Dioxide | IP IP | 40 Q.S. | mg |
| Disulfiram Tablets 200 mg | Each uncoated tablet contains Disulfiram Excipients | IP | 200 Q.S. | mg |
| Deflazacort Tablets 18 mg | Each uncoated tablet contains Deflazacort Excipients | 18 Q.S. | mg | |
| Diclofenac Sodium Sustained Release Tablets IP 100 mg | Each sustained release tablet contains Diclofenac Sodium Excipients Approved Colour used | IP | 100 Q.S. | mg |
| Vitamin C, Zinc Citrate , Selenium Tablets | Each Chewable tablet contains Vitamin C Zinc Citrate Selenium Excipients Approved Colour used | 500 2.2 600 Q.S. | mg mg mg |
|
| Telmisartan, Cilnidipine & Chlorthalidone Tablets | Each film coated tablet contains Telmisartan Cilnidipine Chlorthalidone Excipients Colour : Ferric oxide (Red) USP NF | IP IP | 40 10 6.25 Q.S. | mg mg mg |
| Metformin Hydrochloride(SR) & Repaglinide Tablets | Each film coated tablet contains Metformin Hydrochloride Eq. to Metformin (As sustained release) Repaglinide Excipients Approved colour used | IP BP | 500 1 Q.S. | mg mg |
| Metformin Hydrochloride(SR) & Repaglinide Tablets | Each film coated tablet contains Metformin Hydrochloride Eq. to Metformin(As sustained release) Repaglinide Excipients Approved colour used | IP BP | 500 2 Q.S. | mg mg |
| Nimesulide Tablets 100 mg | Each uncoated tablet contains Nimesulide Excipients | BP | 100 Q.S. | mg |
| Nitroglycerin Controlled Release Tablets 6.4 mg | Each uncoated tablet contains Diluted Nitroglycerin Eq. to Nitroglycerin (In Controlled Release form) Excipients Colour: Lake of Erythrosine | IP | 6.4 Q.S. | mg |
| Metoprolol Succinate Prolonged Release & Amlodipine Tablets IP | Each film coated tablet contains Metoprolol Succinate Equiv. to Metoprolol Tartrate (As prolonged release) Amlodipine Besylate Eq. to Amlodipine Excipients Approved Colour Used | IP IP | 47.5 50 5 Q.S. | mg mg mg |
| Amoxycillin Tablets 500 mg | Each film coated tablet contains Amoxycillin Trihydrate Eq.to Amoxycillin Excipients Approved Colour Used | IP | 500 Q.S. | mg |
| Calcitriol, Calcium Carbonate & Zinc Sulphate Monohydrate Tablets | Each film coated tablet contains Calcitriol Calcium Carbonate eq. to Elemental Calcium Zinc Sulphate Monohydrate eq. to elemental Zinc Excipients Approved Colour Used | IP IP IP | 0.25 1250 500 7.5 Q.S. | mg mg mg mg |
| Cefixime Dispersible Tablets 400 mg | Each dispersible tablet contains Cefixime Trihydrate Eq. to Anhydrous Cefixime Excipients | IP | 400 Q.S. | mg |
| Cephalexin dispersible tablets IP 250 mg | Each dispersible tablet contains Cephalexin eq.to anh. Cephalexin Excipients Colour: Tartrazine Each hard gelatin capsule contains | IP | 250 Q.S. | mg |
| Rabeprazole Sodium & Ondansetron Tablets | Each gastro resistant tablet contains Rabeprazole Sodium Eq. to Rabeprazole Ondansetron HCl Eq. to Ondansetron Excipients Colour : Sunset Yellow FCF | IP IP | 20 4 Q.S. | mg mg |
| Dapagliflozin Tablets 10 mg | Each film coated tablet contains Dapagliflozin Propanediol Monohydrate eq.to Dapagliflozin Excipients Colour: Titanium Dioxide | IP | 10 Q.S. | mg |
| Deflazacort Tablets | Each uncoated tablet contains Deflazacort Excipients | 12 Q.S. | mg | |
| Diclofenac Potassium, Paracetamol and Chlorzoxazone Tablets | Each film coated tablet contains: Diclofenac Potassium Paracetamol Chlorzoxazone Excipients Approved Colour used | IP IP USP | 50 325 500 Q.S. | mg mg mg |
| Divalproex Extended Release Tablets IP 250 mg | Each extended release tablet contains Divalproex Sodium Eq. to Valproic Acid Excipients Approved Colour used | IP | 250 Q.S. | mg |
| Divalproex Extended Release Tablets IP 500 mg | Each extended release tablet contains Divalproex Sodium Eq. to Valproic Acid Excipients Approved Colour used | IP | 500 Q.S. | mg |
| Zinc Acetate Tablets | Each enteric coated tablet contains Zinc Acetate (as dihydrate) Eq. to elemental Zinc Excipients Approved Colour used | USP | 167.86 50 Q.S. | mg mg |
| Ferrous Ascorbate, Folic Acid & Zinc Sulphate Tablet | Ferrous Ascorbate, Folic Acid & Zinc Sulphate Tablet Ferrous ascorbate eq. to Elemental iron Folic acid Zinc Sulphate monohydrate Eq. to Elemental Zinc Excipients Approved colour used | IP | 100 1.5 22.5 Q.S. | mg mg mg |
| Nitroglycerine sustained Release Tablets 2.6 mg | Each sustained release tablet contains Nitroglycerine Excipients Colour: Lake of Erythrosine | IP | 2.6 Q.S. | mg |
| Pancreatin, Simethicone & Activated Charcoal Tablets | Each film coated tablet contains Pancreatin Simethicone Activated Charcoal Excipients Approved colour used | IP IP IP | 175 50 50 Q.S. | mg mg |
| Paracetamol SR 1000mg Tablets | Each sustained release bilayered tablet contains Paracetamol Excipients | IP | 1000 Q.S. | mg |
| Paracetamol & Domperidone Tablets | Each uncoated dispersible tablet contains Paracetamol Domperidone Excipients | IP IP | 35 10 Q.S | mg mg |
| Paracetamol , Phenylephrine HCl, Levocetirizine, Chlorpheniramine Maleate Tablets | Each uncoated tablet contains Paracetamol Phenylephrine HCl Levocetirizine Dihydrochloride Chlorpheniramine Maleate Excipients Colour: approved colour used | IP IP IP IP | 500 5 5 4 Q.S. | mg mg mg mg |
| Pregabalin, Methylcobalamin & Nortriptyline Tablets | Each film coated tablet contains Pregabalin Methylcobalamin Nortriptyline HCl Eq. to Nortriptyline Excipients Colour: Approved Colour used | IP IP IP | 75 1500 10 Q.S. | mg mg mg |
| Thiocolchicoside & Aceclofenac Tablets | Each film coated tablet contains Thiocolchicoside Aceclofenac Excipients Approved colour used | IP IP | 4 100 Q.S. | mg mg |
| Levocetirizine & Montelukast Sodium dispersible Tablets | Each uncoated dispersible tablets contains Levocetirizine Dihydrochloride Montelukast Sodium eq. to Montelukast Excipients Approved colour used | IP IP | 2.5 4 Q.S. | mg mg |
| Cilnidipine & Olmesartan Medoxomil Tablets | Each film coated tablet contains Olmesartan Medoxomil Cilnidipine Excipients Approved colour used | IP IP | 20 10 | mg mg |
| Albendazole Chewable Tablets 200mg | Each chewable tablet contains Albendazole Excipients | IP | 200 Q.S. | mg |
| Amlodipine Besylate & Hydrochlorothiazide Tablets | Each uncoated tablet contains Amlodipine Besylate eq. to Amlodipine Hydrochlorothiazide Excipients | IP IP | 5 12.5 Q.S. | mg mg |
| Losartan Potassium & Amlodipine Tablets | Each uncoated tablet contains Losartan Potassium Amlodipine Besylate eq. to Amlodipine Excipients | IP IP | 25 5 Q.S. | mg mg |
| Metoprolol Succinate Prolonged release & Amlodipine Tablets IP | Each film coated tablet contains Metoprolol Succinate( as Prolonged release ) equiv. to Metoprolol Tartrate Amlodipine Besylate Eq. to Amlodipine Excipients Approved Colour Used | IP IP | 25 5 Q.S. | mg mg |
| Bisoprolol fumarate 5mg & Amlodipine 5mg Tablets | Each film coated tablet contains Bisoprolol fumarate Amlodipine Besylate Eq. to Amlodipine Excipients Approved Colour Used | IP IP | 5 5 Q.S. | mg mg |
| Amlodipine besylate & Nebivolol Hydrochloride Tablets | Each uncoated tablet contains Amlodipine Besylate Eq. to Amlodipine Nebivolol Hydrochloride Eq. to Nebivolol Excipients | IP IP | 5 5 Q.S. | mg mg |
| Amlodipine besylate Tablets 10 mg | Each uncoated tablet contains Amlodipine Besylate Eq. to Amlodipine Excipients | IP | 10 Q.S. | mg |
| Amlodipine besylate & Nebivolol Hydrochloride Tablets | Each uncoated tablet contains Amlodipine Besylate Eq. to Amlodipine Nebivolol Hydrochloride Eq. to Nebivolol Excipients | IP IP | 10 5 Q.S. | mg mg |
| Amlodipine, Valsartan & Hydrochlorothiazide Tablets | Each film coated tablet contains Amlodipine Besylate Eq. to Amlodipine Valsartan Hydrochlorothiazide Excipients Approved Colour used | IP IP | 5 320 2.5 Q.S. | mg mg mg |
| Amlodipine, Valsartan & Hydrochlorothiazide Tablets | Each film coated tablet contains Amlodipine Besylate Eq. to Amlodipine Hydrochlorothiazide Valsartan Excipients Approved Colour used | IP USP IP | 2.5 80 12.5 Q.S. | mg mg mg |
| Amlodipine, Valsartan & Hydrochlorothiazide Tablets | Each film coated tablet contains Amlodipine Besylate Eq. to Amlodipine Valsartan Hydrochlorothiazide Excipients Approved Colour used | IP USP IP | 10 325 25 Q.S. | mg mg mg |
| Amoxycillin dispersible Tablets IP 125 mg | Each dispersible tablet contains Amoxycillin Trihydrate Eq.to Amoxycillin Excipients Approved Colour used | IP | 125 Q.S. | mg |
| Artemether & Lumefantrine Tablets | Each uncoated tablet contains Artemether Lumefantrine Excipients | IP | 20 120 Q.S. | mg mg |
| Artemether & Lumefantrine Tablets | Each uncoated tablet contains Artemether Lumefantrine Excipients | IP | 40 240 Q.S. | mg mg |
| Atorvastatin & Ezetimibe Tablets | Each film coated tablet contains Atorvastatin Calcium Eq. to Atorvastatin Ezetimibe Excipients Approved Colour used | IP IP | 10 10 Q.S. | mg mg |
| Azithromycin Dispersible tablets 100 mg | Azithromycin (as dihydrate ) Eqv.to anhydrous Azithromycin Excipients | IP | 100 Q.S. | mg |
| Etodolac Prolonged Release tablets IP | Etodolac Excipients approved colour used | IP | 600 Q.S. | mg |
| Benidipine Hydrochloride Tablets 4 mg | Each film coated tablet contains Benidipine Hydrochloride Excipients Approved Colour used | 4 Q.S. | mg | |
| Benidipine Hydrochloride Tablets 8 mg | Each film coated tablet contains Benidipine Hydrochloride Excipients Approved Colour used | 8 Q.S. | mg | |
| Bisoprolol Fumarate Tablets | Bisoprolol Fumarate Excipients Approved Colour used | USP | 2.5 Q.S. | mg |
| Bisoprolol Fumarate Tablets | Bisoprolol Fumarate Excipients Approved Colour used | USP | 2.5 Q.S. | mg |
| Cefixime (SR) 400 mg & Moxifloxacin (SR) 400 mg Tablets | Each film coated tablet contains Cefixime Trihydrate Eq. to anhydrous Cefixime Moxifloxacin HCl Eq. to Moxifloxacin Excipients Approved colour used | IP IP | 400 400 Q.S. | mg mg |
| Baclofen Tablets 25 mg | Each uncoated tablet contains Baclofen Excipients | USP | 25 Q.S. | mg |
| Fluoxetine Hydrochloride and Olanzapine Tablets | Each Uncoated tablet contains Fluoxetine Hydrochloride Olanzapine Excipients Approved colour used | USP IP | 20 5 Q.S. | mg mg |
| Etodolac and Thiocolchicoside Tablets | Each film coated tablet contains Etodolac Thiocolchicoside Excipients Approved colour used | IP IP | 300 8 Q.S. | mg mg |
| Etodolac and Thiocolchicoside Tablets | Each film coated tablet contains Etodolac Thiocolchicoside Excipients Approved colour used | IP IP | 300 4 Q.S. | mg mg |
| Etodolac and Paracetamol Tablets | Each film coated tablet contains Etodolac Paracetamol Excipients Approved colour used | IP IP | 300 500 Q.S. | mg mg |
| Doxofylline (SR) & Montelukast Sodium Tablets | Each uncoated sustained release Tablet contains Doxofylline (as sustained release) Montelukast Sodium eq. to Montelukast Excipients | IP IP | 800 10 Q.S. | mg mg |
| Divalproex Extended Release Tablets IP 750 mg | Each extended release tablet contains Divalproex Sodium Eq. to available Valproic Acid Excipients Approved colour used | IP | 750 Q.S. | mg |
| Diltiazem Hydrochloride SR Tablets IP 90 mg | Each film coated sustained release tablet contains Diltiazem Hydrochloride Excipients Approved colour used | IP | 90 Q.S. | mg |
| Diclofenac Sodium SR Tablets IP 150 mg | Each sustained release tablet contains Diclofenac Sodium Excipients Approved colour used | IP | 150 Q.S. | mg |
| Cefixime & Sulbactum Tablets | Each film coated tablets contains Cefixime (Eq. to Anhydrous Cefixime) Sulbactum Sodium Eq. to Sulbactum Excipients approved colour used | IP BP | 200 150 Q.S. | mg mg |
| Dexibuprofen & Paracetamol Tablets | Each uncoated tablet contains Dexibuprofen Paracetamol Excipients | IP | 300 500 Q.S. | mg mg |
| Dapoxetine Hydrochloride Tablets IP 30 mg | Each film coated tablet contains Dapoxetine Hydrochloride Eq. to Dapoxetine Excipients Approved colour used | IP | 30 Q.S. | mg |
| Dapoxetine Hydrochloride Tablets IP 60 mg | Each film coated tablet contains Dapoxetine Hydrochloride Eq. to Dapoxetine Excipients Approved colour used | IP | 60 Q.S. | mg |
| Clotrimazole Vaginal Tablets IP 100 mg | Each uncoated vaginal tablet contains Clotrimazole Excipients | IP | 100 Q.S. | mg |
| Cefpodoxime & Dicloxacillin (ER) Tablets | Each film coated tablet contains Cefpodoxime Proxetil Eq. to Cefpodoxime Dicloxacillin Sodium Eq. to Dicloxacillin (as extended release) Excipients Approved colour used | IP IP | 100 500 Q.S. | mg mg |
| Cefixime,Azithromycin and lactic acid Bacillus Tablets | Each film coated tablet contains Cefixime (as trihydrate) eq. to anh cefixime Azithromycin dihydrate eq. to (anh) Azithromycin lactic acid bacillus excipients Colour: approved colour used | IP IP | 200 250 60 Q.S. | mg mg Million spores |
| Azithromycin oral suspension IP | Each 5 ml contains: Azithromycin Dihydrate eq. to (anh) Azithromycin In a flavoured syrupy base Excipients approved colour used | IP | 100 Q.S. | mg mg |
| Azithromycin & Lactic acid Bacillus Tablets | Each filmcoated Tablet contains: Azithromycin Dihydrate eq. to (anh) Azithromycin lactic acid bacillus excipients Colour ponceau 4R | IP | 500 60 Q.S. | mg mg Million spores |
| Acotiamide Tablets 100 mg | Each film coated tablet contains Acotiamide hydrochloride hydrate Excipients Approved colour used | 100 Q.S. | mg | |
| Rivaroxaban Tablets 20 mg | Each film coated tablet contains Rivaroxaban Micronized Excipients Approved colour used | 20 Q.S. | mg | |
| Tolperisone Hydochloride & Paracetamol Tablets | Each film coated tablet contains Tolperisone Hydochloride Paracetamol Excipients Approved colour used | IP | 150 500 Q.S. | mg mg |
| Cilnidipine & Metoprolol Succinate ER Tablets | Each film coated bilayered tablet contains Cilnidipine Metoprolol Succinate Eq. to Metoprolol Tartrate (As extended release) Excipients Approved colour used | IP IP | 10 47.5 50 Q.S. | mg mg mg |
| Clomiphene Citrate Tablets IP 50 mg | Each uncoated tablet contains Clomiphene Citrate Excipients | IP | 50 Q.S. | mg |
| Torsemide & Spironolactone Tablets | Each film coated tablet contains Torsemide Spironolactone Excipients Approved Colour used | IP IP | 20 50 Q.S. | mg mg |
| Calcium Citrate, Magnesium Hydroxide , Zinc Sulphate Monohydrate & calcitriol tablets | Each film coated tablet contains Calcium Citrate Magnesium hydroxide Eq.to Elemental Magnesium Eq.to Elemental Zinc Calcitriol Excipients Approved Colour used | USP IP IP IP | 750 100 7.5 0.25 Q.S. | mg mg mg mg |
| Paracetamol suspension IP 150 mg | Each ml contains Paracetamol flavoured syrupy base Approved Colour used Colour : Yellow Oxide of Iron | IP | 150 Q.S. | |
| Trypsin, Bromelain, Rutoside Trihydrate & Aceclofenac Tablets | Each enteric coated tablet contains Trypsin Bromelain Rutoside Trihydrate Aceclofenac Excipients approved colour used | BP BP IP | 48 90 100 100 Q.S. | mg mg mg mg |
| Trypsin, Bromelain, Rutoside Trihydrate & DIclofenac Sodium Tablets | Each enteric coated tablet contains Trypsin Bromelain Rutoside Trihydrate Excipients approved colour used | BP BP | 48 90 100 Q.S. | mg mg mg |
| Trypsin, Bromelain & Rutoside Trihydrate Tablets | Each enteric coated tablet contains Trypsin Bromelain Rutoside Trihydrate Excipients approved colour used | BP BP | 96 180 200 Q.S. | mg mg mg |
| Voglibose, Glimepiride & Metformin (SR) Tablets | Each uncoated tablet contains Voglibose Glimepiride Metformin Hydrochloride (SR) Excipients Approved colour used | IP IP IP | 0.3 1 500 Q.S. | mg mg mg |
| Voglibose, Glimepiride & Metformin (SR) Tablets | Each uncoated tablet contains Voglibose Glimepiride Metformin Hydrochloride (SR) Excipients Approved colour used | IP IP IP | 0.3 2 500 Q.S. | mg mg mg |
| Ofloxacin & Flavoxtate Tablets | Each film coated tablet contains Ofloxacin Flavoxtate Hydrochloride Excipients Approved colour used in coating | IP IP | 200 200 Q.S. | mg mg |
| Flunarizine, Domperidone and Paracetamol Tablets | Each film coated tablet contains Flunarizine Dihydrochloride Eq.to Flunarizine Domperidone Paracetamol Excipients Approved colour used in coating | BP IP | 5 10 325 Q.S. | mg mg mg |
| Flupenthixol Tablets | Each film coated tablet contains Flupenthixol Dihydrochloride Eq.to Flupenthixol Excipients Approved colour used in coating | BP | 0.5 Q.S. | mg |
| Quetiapine Tablets IP 25 mg | Approved colour used in coating Each film coated tablet contains Quetiapine fumarate Eq.to Quetiapine Excipients Approved colour used | IP | 25 Q.S. | mg |
| Chlorthalidone , Amlodipine & Telmisartan Tablets | Each film coated tablet contains Chlorthalidone Amlodipine besylate Eq.to amlodipine Telmisartan Hydrochloride Excipients Approved colour used | IP IP IP | 12.5 5 80 Q.S. | mg mg mg |
| Prochlorperazine Maleate Tablets IP | Each film coated tablet contains Prochlorperazine Maleate Excipients Approved colour used | IP | 5 Q.S | mg |
| Sulfasalazine USP 500 mg Tablet | Each Delayed release tablet contains Sulfasalazine Excipients Approved colour used | USP | 500 Q.S. | mg |
| Griseofulvin Tablets IP 500mg | Each uncoated tablet contains Griseofulvin Excipients | IP | 500 Q.S. | mg |
| Lansoprazole orally Disintegrate Tablets 15 mg | Each orally disintegrate tablet contains Lansoprazole ( as sustained release pellets) Excipients Approved colour used | IP | 15 Q.S. | mg |
| Lansoprazole orally Disintegrate Tablets 30mg | Lansoprazole ( as sustained release pellets) Excipients Approved colour used | IP | 30 Q.S. | mg |
| Calcium citrate maleate , Vitamin k2-7 ,Calcitriol ,Zinc sulphate monohydrate tablets | Each film coated tablet contains Calcium Citrate Maleate Eq. to Elemental Calcium Calcitriol vitamin K2-7 Zinc sulphate monohydrate Excipients Approved colour used | IP IP | 1200 250 0.25 45 7.5 Q.S. | mg mg mg mg mg |
| Satranidazole Tablets | Each film coated tablet contains Satranidazole Excipients Approved color used | IP | 300 Q.S. | mg |
| Paracetamol and Chlorpheniramine Maleate & Phenylephrine Syrup | Each 5 ml contains Paracetamol Chlorpheniramine Maleate Phenylephrine Hydrochloride flavoured syrupy base | IP IP IP | 250 2 5 Q.S. | mg mg mg |
| Diacerein, Glucosamine Sulphate, Potassium chloride Tablets | Each film coated tablet contains Diacerein Glucosamine Sulphate Potassium chloride Excipients Approved color used | IP USP | 50 750 Q.S. | mg mg |
| Ginko Biloba, Piracetam & Vinopocetine Tablets | Each film coated tablet contains Ginko Biloba extract Piracetam Vinopocetine Excipients | IP | 60 800 5 Q..S. | mg mg mg |
| Cefixime, Dicloxacillin Sodium & Lactic Acid Bacillus Tablets | Each film coated tablet contains Cefixime (Eq. to Anhydrous Cefixime) Dicloxacillin Sodium Eq. to Dicloxacillin (As Extended release) Lactic Acid Bacillus Excipients Approved color used | IP IP | 200 500 90 Q.S. | mg mg Million Spores |
| Saxagliptin 2.5mg + Metformin HCl 500mg tablets | Each film coated tablet contains Saxagliptin hydrochloride eq. to saxagliptin Metformin HCl Excipients Approved color used | IP | 2.5 500 Q.S. | mg mg |
| Saxagliptin 5 mg + Metformin HCl 500 mg tablets | Each film coated tablet contains Saxagliptin hydrochloride eq. to saxagliptin Metformin HCl Excipients Approved color used | IP | 5 500 Q.S. | mg mg |
| Sodium Picosulfate 10mg tablets | Each Uncoated tablet contains Sodium Picosulfate Excipients | BP | 10 Q.S. | mg |
| Saxagliptin 2.5 mg tablets | Each film coated tablet contains Saxagliptin hydrochloride eq. to saxagliptin Excipients Approved color used | 2.5 Q.S. | mg | |
| Saxagliptin 5.0 mg tablets | Each film coated tablet contains Saxagliptin hydrochloride eq. to saxagliptin Excipients Approved color used | 5 Q.S. | mg | |
| Cefixime, Oflaxacin & Lactic Acid Bacillus tablets | Each film coated tablet contains Cefixime (as Trihydrate) (Eq. to Anhydrous Cefixime) Oflaxacin Lactic Acid Bacillus Excipients Approved color used | IP IP | 200 200 60 Q.S. | mg mg mg |
| Nevibolol Hydrochloride Tablets 10 mg | Each uncoated tablet contains Nevibolol Hydrochloride Eq. to Nevibolol Excipients | IP | 10 Q.S. | mg |
| Pancreatin, Simethicone & Activated Charcoal Tablets | Each film coated tablet contains Pancreatin Simethicone Activated Charcoal Excipients Approved color used | IP IP IP | 175 50 50 Q.S. | mg mg mg |
| Terbinafine Tablets USP 500mg | Each uncoated tablet contains Terbinafine Hydrochloride Eq. Terbinafine Excipients | USP | 500 Q.S. | mg |
| Acarbose Tablets IP 25 mg | Each film coated tablet contains Acarbose Excipients Approved color used | IP | 37.5 Q.S. | mg |
| Sulphamethoxazole & Trimethoprim Tablets | Each film coated tablet contains Sulphamethoxazole Trimethoprim Excipients Approved color used | IP IP | 800 160 Q.S. | mg mg |
| N-Acetyl -L-cysteine & Ambroxol Hydrochloride Tablets | Each Film coated tablet contains N-Acetyl L-cysteine Ambroxol Hydrochloride Excipients Excipients | USP IP | 200 30 Q.S. | mg mg |
| Omeprazole Magnesium & Ondansetron Hydrochloride Tablets | Each Film coated tablet contains Omeprazole Magnesium Eq. to Omeprazole Ondansetron Hydrochloride Eq. to Ondansetron Excipients Approved color used | IP IP | 10 4 Q.S. | mg mg |
| Methylcobalamin, L- Methylfolate Calcium & Pyridoxal 5-sulphate Tablets | Each film coated tablet contains Methylcobalamin L- Methylfolate calcium Pyridoxal 5-sulphate Excipients Approved colour used | IP USP USP | 1500 1 5 Q.S. | mg mg mg |
| Amoxycillin + Clavulanic acid tablets | Each film coated tablet contains Potassium Clavulanate eq. to Clavulanic acid Amoxycillin Trihydrate eq.to of Amoxycillin Excipients Approved colour used | IP IP | 125 250 Q.S. | mg mg |
| Amoxycillin + Clavulanic acid tablets | Each film coated tablet contains Potassium Clavulanate eq. to Clavulanic acid Amoxycillin Trihydrate eq.to of Amoxycillin Excipients Approved colour used | IP IP | 125 875 Q.S. | mg mg |
| Metformin Hydrochloride(SR), Repaglinide Tablets | Each film coated tablet contains Metformin Hydrochloride (As sustained release Form) Repaglinide Excipients Approved colour used | IP IP | 500 1 Q.S. | mg mg |
| Metformin Hydrochloride(SR), Repaglinide Tablets | Each film coated tablet contains Metformin Hydrochloride As sustained release Form Repaglinide Excipients Approved colour used | IP IP | 500 2 Q.S. | mg mg |
| Omeprazole Magnesium and Ondansteron HCl Tablets | Each film coated tablet contains Omeprazole Magnesium Eq. to Omeprazole Ondansteron HCl Eq. to Ondansteron ExcipientsApproved colour used | IP | 40 10 Q.S. | mg mg |
| S-Adenosyl-L-Methionine Tablet | Each Film Coated Tablet Contains S-Adenosyl-L-Methionine Excipients Approved colour used in coating | 400 Q.S. | mg | |
| Acetylcysteine tablets | Each Effervescent Tablet Contains Acetylcysteine Excipients Approved colour used in coating | USP | 600 Q.S. | mg |
| Cetirizine Hydrochloride & Phenylephrine Hydrochloride Tablet | Each Film Coated Tablet Contains Cetirizine Hydrochloride Phenylephrine Hydrochloride Excipients Approved colour used in coating | IP IP | 5 10 Q.S. | mg mg |
| Bepotastine Besilate Tablets | Each film coated tablet contains Bepatostine Besilate Excipients Approved colour used in coating | 10 Q.S. | mg | |
| Mefenamic Acid, Paracetamol & Dicyclomine Hydrochloride Tablets | Each uncoated tablet contains Mefenamic Acid Paracetamol Dicyclomine Hydrochloride Excipients | IP IP IP | 250 325 10 Q.S. | mg mg mg |
| Doxylamine Succinate & Pyridoxine HCl Tablets | Each enteric coated Tablet contains Doxylamine Succinate Pyridoxine HCl Excipients Approved colour used | USP IP | 10 10 Q.S. | mg mg |
| Methylcobalamin Tablet | Each film coated tablet contains Methylcobalamin Excipients Approved colour used | IP | 1500 Q.S. | mcg |
| Loratadine Tablets | Each uncoated Tablet contains Loratadine Excipients Approved colour used | BP | 10 Q.S. | mg |
| Serratiopeptidase Tablets | Each film coated Tablet contains Serratiopeptidase Excipients Approved colour used | IP | 10 Q.S. | mg |
| Ofloxacin Tablets | Each Film coated Tablet contains Ofloxacin Excipients Approved colour used in coating | IP | 400 Q.S. | mg |
| Cefuroxime Axetil Tablets IP | Each Film coated Tablet contains Cefuroxime Axetil Eq. to Cefuroxime Excipients Approved colour used in coating | IP | 250 Q.S. | mg |
| Cefpodoxime Proxetil Tablets IP | Each Film coated Tablet contains Cefpodoxime Proxetil Eq. to Cefpodoxime Excipients Approved colour used in coating | IP | 200 Q.S. | mg |
| Ursodeoxycholic Acid Tablets IP 150 mg | Each uncoated Tablet contains Ursodeoxycholic acid Excipients | IP | 150 Q.S. | mg |
| Pantoprazole Sodium & Domperidone tablets | Each Enteric coated tablet contains Pantoprazole Sodium Eq. to Pantaprazole Domperidone Excipients Approved colour used | IP BP | 40 10 Q.S. | mg mg |
| Azithromycin Tablets IP 500 mg | Each Film coated tablet contains Azithromycin Dihydrate Eq. to Azithromycin Excipients Approved colour used in coating | IP | 500 Q.S. | mg |
| Aspirin Dispersible Tablets IP 75 mg | Each Dispersible tablet contains Aspirin Excipients | IP | 75 Q.S. | mg |
| Aspirin Dispersible Tablets IP 150 mg | Each Dispersible tablet contains Aspirin Excipients | IP | 150 Q.S. | mg |
| Ofloxacin & Lactic Acid Bacillus Tablets | Each Film Coated Tablet contains Ofloxacin Lactic Acid Bacillus Excipients Approved colour used in coating | IP | 200 60 Q.S. | mg Million Spores |
| Prochlorperazine Maleate Mouth Dissolving Tablet | Each Uncoated Mouth Dissolving Tablet contains Prochlorperazine Maleate Excipients | IP | 5 Q.S. | mg |
| Rivaroxaban Tablets 10 mg | Each film coated tablet contains Rivaroxaban Excipients Approved colour used | 10 Q.S. | mg | |
| Rivaroxaban Tablet 15 mg | Each film coated tablet contains Rivaroxaban Excipients Approved colour used | 15 Q.S. | mg | |
| Cinnarizine Sustained Release Tablet | Each Sustained Release Tablet contains Cinnarizine Excipients Approved colour used | IP | 75 Q.S. | mg |
| Azithromycin & Lactic Acid bacillus Tablets | Each Film coated Tablet contains Azithromycin Dihydrate Eq. to Azithromycin Anhydrous Lactic Acid Bacilus Excipients Approved colour used | IP | 250 60 Q.S. | mg Million Spores |
| Ascorbic Acid, Sodium Ascorbate and Zinc Chewable Tablets | Each Chewable Tablet contains Ascorbic Acid Sodium Ascorbate Eq. to Ascorbic Acid Zinc Citrate Zinc Citrate Excipients Approved colour used | IP IP IP | 100 450 400 5 Q.S. | mg mg mg mg |
| Paracetamol, Phenylephrine HCl, Caffeine & Diphenhydramine Hydrochloride Tablets | Each uncoated tablet contains Paracetamol Phenylephrine HCl Caffeine anhydrous Eq. to Caffeine Diphenhydramine Hydrochloride Excipients | IP IP IP IP | 325 5 30 25 Q.S. | mg mg mg mg |
| L-Ornithine L-Aspartate & Pancreatin Tablets | Each Film coated tablet contains L-Ornithine L-Aspartate Pancreatin Excipients Approved colour used | IP | 150 100 Q.S. | mg mg |
| Terbinafine Hydrochloride & Itraconazole Tablets | Each Film coated tablet contains Terbinafine Hydrochloride Eq. to Terbinafine Itraconazole Excipients Approved colour used | IP BP | 250 200 Q.S. | mg mg |
| Doxycycline Hydrochloride & Lactic Acid Bacillus Tablets | Each Film coated tablet contains Doxycycline Hydrochloride Eq. to Doxycycline Lactic Acid Bacillus Excipients Approved colour used | IP | 100 90 Q.S. | mg mg Million Spores |
| Rosuvastatin Calcium & Clopidogrel Bisulphate tablets | Each Film coated Tablet contains Rosuvastatin Calcium eq. to Rosuvastatin Clopidogrel Bisulphate eq. to Clopidogrel Excipients Approved colour used in coating | IP IP | 5 75 Q.S. | mg mg |
| Rosuvastatin Calcium & Clopidogrel Bisulphate tablets | Each Film coated Tablet contains Rosuvastatin Calcium eq. to Rosuvastatin Clopidogrel Bisulphate eq. to Clopidogrel Excipients Approved colour used in coating | IP IP | 10 75 Q.S. | mg mg |
| Terbinafine Hydrochloride & Itraconazole Tablets | Each Film coated tablet contains Terbinafine Hydrochloride Eq. to Terbinafine Itraconazole Excipients | IP BP | 250 100 Q.S. | mg mg |
| Rosuvastatin 5 mg & Aspirin 75 tablet | Each Film coated tablet contains Rosuvastatin Calcium eq. to Rosuvastatin Aspirin Excipients Approved colour used | IP IP | 5 75 Q.S. | mg mg |
| Rosuvastatin 10mg & Aspirin 75 mg tablet | Each Film coated tablet contains Rosuvastatin Calcium eq. to Rosuvastatin Aspirin Excipients Approved colour used | IP IP | 10 75 Q.S. | mg mg |
| Rosuvastatin 10 mg & Aspirin 150 tablet | Each Film coated tablet contains Rosuvastatin Calcium eq. to Rosuvastatin Aspirin Excipients Approved colour used | IP IP | 10 150 Q.S. | mg mg |
| Cefixime & Lactic Acid Bacillus Tablets | Each uncoated dispersible tablet contains Cefixime Trihydrate Eq. to Anhydrous Cefixime Lactic Acid Bacillus Excipients | IP IP | 200 60 Q.S. | mg Million Spores |
| Pirfenidone 200 mg Tablets | Each Film coated Tablet contains Pirfenidone Excipients Approved colour used | IP | 200 Q.S. | mg |
| Pirfenidone 400 mg Tablets | Each Film coated Tablet contains Pirfenidone Excipients Approved colour used | IP | 400 Q.S. | mg |
| Pantoprazole Sodium & Ondansetron Tablets | Each gastro resistant tablet contains Pantoprazole Sodium eq. to Pantoprazole Ondansetron Hydrochloride ExcipientsApproved colour used | IP IP | 40 4 Q.S. | mg mg |
| Etoricoxib & Paracetamol Tablets | Each film coated tablet contains Etoricoxib Paracetamol Excipients Approved colour used | IP IP | 60 325 Q.S. | mg mg |
| Cefuroxime & Clavulanic Acid Tablets | Each Film coated Tablet contains Cefuroxime Axetil Eq. to Cefuroxime Potassium Clavulanate Diluted Eq. to Clavulanic Acid Excipients Approved colour used in coating | IP IP | 250 125 Q.S. | mg mg |
| Cefuroxime Axetil 500mg and Clavulanic Acid 125 mg Tablets | Each Film coated Tablet contains Cefuroxime Axetil Eq. to Cefuroxime Potassium Clavulanate Diluted Eq. to Clavulanic Acid Excipients Approved colour used in coating | IP IP | 500 125 Q.S. | mg mg |
| Cefixime dispersible tablets | Each dispersible tablet contains Cefixime Trihydrate Eq. to Anhydrous Cefixime Excipients | IP | 200 Q.S. | mg |
| Ethamsylate Tablets | Each uncoated tablet contains Ethamsylate Excipients Approved colour used | BP | 500 Q.S. | mg |
| Mirtazapine Tablets 7.5 mg | Each film coated tablet contains Mirtazapine Excipients Approved colour used in coating | IP | 7.5 Q.S. | mg |
| Vitamin C, Zinc sulphate & vitamin D3 tablet | Each uncoated chewable tablet contains: Vitamin C Zinc Sulphate Vitamin D3 Excipients Approved Colour Used | 500 22.5 400 Q.S. | mg mg mg |
|
| Calcium Carbonate, vitamin D3 Magnesium Hydroxide , Zinc & copper Tablets | Each film coated tablet contains Calcium Carbonate eq. to Elemental calcium Vitamin D3 Magnesium Hydroxide Eq.to Elemental Magnesium Zinccopper Excipients Approved Colour used | IP IP IP IP IP | 1250 500 400 40 1.8 4 1 Q.S. | mg mg mg mg mg mg mg |
| Ranolazine ER tablets | Each film coated Extended Release tablet contains Ranolazine Excipients Approved colour used in coating | IP | 1000 Q.S. | Calcium Carbonate, vitamin D3 Magnesium Hydroxide , Zinc & copper Tablets |
| Prasugrel Tablets | Each film coated tablet contains Prasugrel Hydrochloride Eq. to Prasugrel Excipients Approved colour used in coating | IP | 10 Q.S. | mg |
| Solifenacin Succinate Tablets 5 mg | Each film coated tablet contains Solifenacin Succinate Excipients Approved colour used in coating | IP | 5 Q.S. | mg |
| Valsartan Tablets 40 mg | Each film coated tablet contains Valsartan Excipients Approved colour used in coating | IP | 40 Q.S. | mg |
| Valsartan Tablets 80 mg | Each film coated tablet contains Valsartan Excipients Approved colour used in coating | IP | 80 Q.S. | mg |
| Valsartan Tablets 160 mg | Each film coated tablet contains Valsartan Excipients Approved colour used in coating | IP | 160 Q.S. | mg |
| Prazosin Hydrochloride Tablets 5 mg | Each uncoated tablet contains Prazosin Hydrochloride ( as sustained release ) Excipients Approved colour used in coating | IP | 5 Q.S. | mg |
| Topiramate Tablets 25 mg | Each film coated tablet contains Topiramate Excipients Approved colour used in coating | IP | 25 Q.S. | mg |
| Topiramate Tablets 50 mg | Each film coated tablet contains Topiramate Excipients Approved colour used in coating | IP | 50 Q.S. | mg |
| Atorvastatin Tablets 80 mg | Each film coated tablet contains Each film coated tablet contains Excipients Approved colour used | IP | 80 Q.S. | mg |
| Glimepiride & Metformin (SR) Tablets | Each film coated tablet contains Glimepiride Metformin HCl Excipients Approved Colour used | IP IP | 1 1000 Q.S. | mg mg |
| Piracetam Tablets 400 mg | Each film coated tablet contains Piracetam Excipients Approved colour used in coating | IP | 400 Q.S. | mg |
| Piracetam Tablets 800 mg | Each film coated tablet contains Each film coated tablet contains Excipients Approved colour used in coating | IP | 800 Q.S. | mg |
| Ursodeoxycholic Acid Tablets IP 450mg | Each uncoated tablets contains Ursodeoxycholic Acid Excipients | IP | 450 Q.S. | mg |
| Ursodeoxycholic Acid tablets IP 600mg | Each uncoated tablets contains Ursodeoxycholic Acid Excipients Each film coated tablet contains | IP | 600 Q.S. | mg |
| Cefprozil Tablets USP 500 mg | Each film coated tablet contains Cefprozil Excipients Approved colour used in coating | USP | 500 Q.S. | mg |
| Cefprozil Tablets USP 250mg | Each film coated tablet contains Cefprozil Excipients Approved colour used | USP | 250 Q.S. | mg |
| Dapagliflozin Tablets 5 mg | Each film coated tablet contains Dapagliflozin Propanediol Monohydrate eq.to Dapagliflozin Excipients Approved colour used | 5 Q.S. | mg | |
| Levocetirizine , Montelukast Sodium & ambroxol Hydrochloride (SR)Tablets | Each film coated tablet contains Levocetirizine Hydrochloride Montelukast Sodium eq. to Montelukast Ambroxol hydrochloride (as sustained release form) Excipients Approved colour used | IP IP IP | 5 10 75 Q.S. | mg mg mg |
| Etodolac and Thiocolchicoside Tablets | Each film coated tablet contains Etodolac Thiocolchicoside Excipients Approved colour used | IP IP | 400 4 Q.S. | mg mg |
| Etodolac and Thiocolchicoside Tablets | Each film coated tablet contains Etodolac Thiocolchicoside Excipients Approved colour used | IP IP | 400 8 Q.S. | mg mg |
| Etodolac and paracetamol Tablets | Each film coated tablet contains Etodolac Paracetamol Excipients Approved colour used | IP IP | 400 500 Q.S. | mg mg |
| Ticagrelor Tablets IP 90mg | Each film coated tablet contains Ticagrelor Excipients Approved colour used | IP | 90 Q.S. | mg |
| Trimetazidine modified release Tablets | Each film coated modified release tablet contains Trimetazidine dihydrochloride Excipients Approved colour used | IP | 35 Q.S. | mg |
| Etofylline and Theophylline Tablets | Each film coated tablet contains Etofylline Theophylline (hydrate ) Excipients Approved colour used | IP IP | 115 35 Q.S. | mg mg |
| Etofylline and Theophylline Tablets | Each film coated tablet contains Etofylline Theophylline (hydrate ) Excipients Approved colour used | IP IP | 231 69 Q.S. | mg mg |
| Levocetirizine , & ambroxol Hydrochloride (SR)Tablets | Each film coated tablet contains Levocetirizine Hydrochloride Ambroxol hydrochloride ( as sustained release form) Excipients Approved colour used | IP IP | 5 75 Q.S. | mg mg |
| Glimepiride & Metformin (SR) Tablets | Each uncoated tablet contains Glimepiride Metformin HCl (as sustained release form) Excipients Approved Colour used | IP IP | 2 1000 Q.S. | mg mg |
| Betahistine Dihydrochloride Sustained Release Tablets IP 48 mg | Each uncoated sustained release tablet contains: Betahistine Dihydrochloride Excipients | IP | 48 Q.S. | mg |
| Ivermectin Tablets 6 mg | Each filmcoated tablet contains Ivermectin Excipients Colour : approved colour used | IP | 6 Q.S. | mg |
| Esomeprazole Delayed Release Tablets IP 20 mg | Each Delayed Release tablet contains Esomeprazole Magnesium Trihydrate Eq. to Esomeprazole Excipients Colour : Approved Colour used | IP | 20 Q.S. | mg |
| Metformin (SR) Tablets | Each uncoated sustained release tablet contains Metformin HCl (as sustained release form) Excipients | IP | 1000 Q.S. | mg |
| Telmisartan & Metprolol Succinate (ER) Tablets | Each uncoated tablet contains Telmisartan Metoprolol Succinate Eq. to Metoprolol Tartrate (As extended Release) Excipients Colour :Approved colour used | IP IP | 40 25 Q.S. | mg mg |
| Prazosin sustained release Tablets IP 2 mg | Each filmcoated tablet contains Prazosin Hydrochloride eq. to Prazosin ( as sustained release ) Excipients Approved colour used in coating | IP | 2 Q.S. | mg |
| Bisoprolol fumarate & Hydrochlorothiazide Tablets | Each film coated tablet contains Bisoprolol fumarate Hydrochlorothiazide Excipients Approved Colour Used | IP IP | 5 6.25 Q.S. | mg mg |
| Methylcobalamin, alpha lipoic acid, folic acid, selenium dioxide ,calcium pantothenate Vitamin B1,Vitamin B6, Vitamin E & Beta Carotene tablets | Each film coated tablets contains Methylcobalamin Alpha lipoic acid folic acid selenium dioxide calcium pantothenate Vitamin B1 Vitamin B6 Vitamin E Beta Carotene (10%) Excipients Approved colour used | IP IP IP IP IP IP IP IP USP | 500 50 1.5 163.6 10 10 1.5 25 20.66 Q.S. | mcg mg mg mcg mg mg mg I.U. mg |
| Voglibose & Metformin (SR) Tablets | Each uncoated tablet contains Voglibose Metformin Hydrochloride (as sustained release form ) Excipients Excipients | IP IP | 0.2 500 Q.S. | mg mg |
| Voglibose & Metformin (SR) Tablets | Each uncoated tablet contains Voglibose Metformin Hydrochloride (as sustained release form ) Excipients Approved colour used | IP IP | 0.3 500 Q.S. | mg mg |
| Paracetamol & Dicyclomine HCl Tablets | Each uncoated tablets contains Paracetamol Dicyclomine HCl Excipients Approved Colour used | IP IP | 325 20 Q.S. | mg mg |
| Ketorolac Tromethamine Tablets IP | Each uncoated tablet contains Ketorolac Tromethamine Excipients Approved colour used | 10 | 10 Q.S. | mg |
| Cinnarizine Tablets IP | Each uncoated tablets contains Cinnarizine Excipients Approved colour used | IP | 25 Q.S. | mg |
| Aceclofenac & Diacerein Tablets | Each Film coated tablets contains Aceclofenac Diacerein Excipients Approved colour used | IP IP | 100 50 Q.S. | mg mg |
| Drotaverin & Mefenamic Tablets | Each film coated tablets contains Drotaverin Hydrochloride Mefenamic Acid Excipients Approved Colour Used | IP IP | 80 250 Q.S. | mg mg |
| Flunarizine Tablets | Each film coated tablets contains Flunarizine Dihydrochloride Excipients Approved Colour Used | BP | 10 Q.S. | mg |
| Mefenamic acid and Tranexamic acid Tablets | Each film coated tablet contains Mefenamic acid Tranexamic acid Excipients Approved colour used | IP | 250 500 Q.S. | mg mg |
| Tranexamic acid Tablets | Each film coated tablet contains Tranexamic acid Excipients Approved colour used | IP | 500 Q.S. | mg |
| Cefixime & Lactic Acid Bacillus Tablet | Each Film coated tablet contains Cefixime Trihydrate Eq. to Anhydrous Cefixime Lactic Acid Bacillus Excipients Approved colour used | IP | 200 60 Q.S. | mg Million Spores |
| Flavoxate Hydrochloride Tablet IP 200 mg | Each film coated tablet Contains Flavoxate HCl Excipients Approved colour used | IP | 200 Q.S. | mg |
| Levofloxacin Tablets IP 500 mg | Each film coated tablets contains Levofloxacin Hemihydrate Eq. to Levofloxacin Excipients Approved colour used in coating | IP | 500 Q.S. | mg |
| Levofloxacin Tablets IP 750 mg | Each film coated tablets contains Levofloxacin Hemihydrate Eq. to Levofloxacin Excipients Approved colour used in coating | IP | 750 Q.S. | mg |
| Febuxostat Tablets IP 80 mg | Each film coated tablets contains Febuxostat Excipients Approved colour used | IP | 80 Q.S. | mg |
| Ursodeoxycholic Acid tablets IP 300mg | Each film coated tablets contains Ursodeoxycholic Acid Excipients Approved colour used in coating | IP | 300 Q.S. | mg |
| Rosuvastatin Tablets IP 10 mg | Each film coated tablet Contains Rosuvastatin Calcium Eq. to Rosuvastatin Excipients Colour: Approved colour used | IP | 10 Q.S. | mg |
| Piroxicam Dispersible Tablets 20 mg | Each uncoated dispersible tablet contains Piroxicam Excipients Approved colour used | IP | 20 Q.S. | mg |
| Doxylamine Succinate, Folic Acid & Pyridoxine HCl Tablets | Each enteric coated Tablet contains Doxylamine Succinate Folic Acid Pyridoxine HCl Excipients Approved colour used | USP IP IP | 10 2.5 10 Q.S. | mg mg mg |
| Doxylamine Succinate, Folic Acid & Pyridoxine HCl Tablets | Each enteric coated Tablet contains Doxylamine Succinate Folic Acid Pyridoxine HCl Excipients Approved colour used | USP IP IP | 20 5 20 Q.S. | mg mg mg |
| Aceclofenac , Paracetamol & Serratiopeptidase Tablets | Each Film coated tablets contains Aceclofenac Paracetamol Serratiopeptidase ( As enteric coated Granules eq. to Enzymatic activity 20,000 units) Excipients Approved colour used | IP IP IP | 100 325 10 Q.S. | mg mg mg |
| Paracetamol , Phenylephrine HCl, Cetirizine Tablets | Each uncoated tablet contains Paracetamol Phenylephrine HCl Cetirizine hydrochloride Excipients Colour: Approved colour used | IP IP IP | 325 10 5 Q.S. | mg mg mg |
| Diclofenac Potassium, Paracetamol & Serratiopeptidase Tablets | Each film coated tablets contains Diclofenac Potassium Paracetamol Serrationpeptidase ( As enteric coated Granules eq. to Enzymatic activity 30,000 units) Excipients Colour: approved colour used in coating | BP IP IP | 50 325 15 Q.S. | mg mg mg |
| Sildenafil Citrate Tablets IP 100 mg | Each film coated tablet contains Sildenafil Citrate Eq. to Sildenafil Excipients Colour : approved colour used | IP | 100 Q.S. | mg |
| Amoxycillin, Potassium Clavulanate & Lactic Acid Bacillus tablets | Each film coated tablet contains Amoxycillin Trihydrate Eq. to Amoxycillin Potassium Clavulanate diluted eq. Clavulanic acid Lactic Acid Bacillus In flavoured Syrupy base Approved colour used | IP | 500 125 60 Q.S. | mg mg Million Spores |
| Cefpodoxime & potassium clavulanate Tablets | Each film coated tablet contains Cefpodoxime Proxetil Eq. to Cefpodoxime Potassium clavulanate diluted eq. to clavulanic acid Excipients Approved colour used | IP IP | 200 125 Q.S. | mg mg |
| Cefixime, Potassium Clavulanate tablets | Each film coated tablet contains Cefixime Trihydrate Eq. to Cefixime Anhydrous Potassium Clavulanate Diluted IP Eq. to Clavulanic Acid Excipients Approved colours used | IP IP | 200 125 Q.S. | mg mg |
| Cefixime & Ofloxacin tablets | Each film coated tablet contains Cefixime Trihydrate (Eq. to Anhydrous Cefixime) Ofloxacin Excipients Approved color used | IP IP | 200 200 Q.S. | mg mg |
| Albendazole Tablets IP | Each chewable tablets contains Albendazole Excipients Colour : Approved colour used | IP | 400 Q.S. | mg |
| Albendazole & Ivermectin Tablets | Each chewable tablets contains Albendazole Ivermectin Excipients Colour : approved colour used | IP IP | 400 6 Q.S. | mg mg |
| Domperidone Tablets | Each uncoated tablet contains Domperidone Excipients Each film coated tablets contains | IP | 10 Q.S. | mg |
| Diclofenac Sodium Tablets IP | Each film coated tablets contains Diclofenac Sodium Excipients Approved Colour used | IP | 50 Q.S. | mg |
| Paracetamol Tablets IP 500 mg | Each uncoated tablets contains Paracetamol Paracetamol | IP | 650 Q.S. | mg |
| Cetirizine Dihydrochloride tablets IP | Each uncoated tablet contains Cetirizine Dihydrochloride Excipients | IP | 10 Q.S. | mg |
| Pantoprazole Tablets IP 40 mg | Each enteric coated tablet contains Pantoprazole Sodium Eq. to Pantoprazole Excipients Approved colour used | IP | 40 Q.S. | mg |
| Folic Acid Tablet IP | Each uncoated tablet contains Folic Acid Excipients Each uncoated tablets contains | IP | 5 Q.S. | mg |
| Atenolol Tablets IP | Each uncoated tablets contains Atenolol Excipients | IP | 50 Q.S. | mg |
| Deflazacort Tablets | Each uncoated tablet contains Deflazacort Excipients | IP | 6 Q.S. | mg |
| Diclofenac Potassium, Paracetamol & Serratiopeptidase Tablets | Each filmcoated tablets contains Diclofenac Potassium Paracetamol Serrationpeptidase ( As enteric coated Granules eq. to Enzymatic activity 20,000 units) ExcipientsColour: approved colour used in coating | BP IP IP | 50 325 10 Q.S. | mg mg mg |
| DIclofenac & Paracetamol Tablets | Each uncoated tablet contains Diclofenac Potassium Paracetamol excipients | IP IP | 50 325 Q.S. | mg mg |
| Ferrous Ascorbate& Folic Acid Tablet | Each film coated tablet contains Ferrous ascorbate eq. to Elemental iron Folic acid Excipients Approved colour used | IP | 100 1.5 Q.S. | mg mg |
| Etamsylate and Tranexamic acid Tablets | Each film coated tablet contains Etamsylate Tranexamic acid Excipients Approved colour used | BP IP | 250 250 Q.S. | mg mg |
| Amoxycillin& Potassium Clavulanate tablet IP | Each film coated tablet contains Amoxycillin Trihydrate eq.to Amoxycillin Potassium Clavulanate diluted eq. to Clavulanic acid Excipients Approved colour used | IP | 500 125 Q.S. | mg mg |
| Linezolid Tablet IP | Each film coated tablet contains Linezolid Excipients Approved colour used | IP | 600 Q.S. | mg |
| Methylprednisolone Tablets IP 4 mg | Each uncoated tablet contains MethylPrednisolone Excipients | ip | 4 Q.S. | mg |
| Levocetirizine & Montelukast Sodium Tablets | Each uncoated tablets contains Levocetirizine Dihydrochloride Montelukast Sodium eq. to Montelukast Excipients Approved colour used | IP IP | 5 10 Q.S. | mg mg |
| Cefixime dispersible tablets IP 100 mg | Each dispersible tablet contains Cefixime Trihydrate Eq. to Anhydrous Cefixime Excipients | IP | 100 Q.S. | mg |
| Ofloxacin Tablets IP | Each Film coated Tablet contains Ofloxacin Excipients Approved colour used in coating | IP | 200 Q.S. | mg |
| Ofloxacin & Ornidazole Tablets | Each film coated tablet contains Ofloxacin Ornidazole Excipients Approved Colour used | IP IP | 200 500 Q.S. | mg mg |
| Cefpodoxime Proxetil Tablets IP | Each uncoated dispersible Tablet contains Cefpodoxime Proxetil Eq. to Cefpodoxime Excipients Approved colour used | IP | 200 Q.S. | mg |
| Cefpodoxime Proxetil Tablets IP | Each uncoated dispersible Tablet contains Cefpodoxime Proxetil Eq. to Cefpodoxime Excipients Approved colour used | IP | 100 Q.S. | mg |
| Cefpodoxime Proxetil Tablets IP | Each uncoated dispersible Tablet contains Cefpodoxime Proxetil Eq. to Cefpodoxime Excipients Approved colour used | IP | 50 Q.S. | mg |
| Amoxycillin dispersible Tablets IP 250 mg | Each dispersible tablet contains Amoxycillin Trihydrate Eq.to Amoxycillin Excipients Approved Colour used | IP | 250 Q.S. | mg |
| Aceclofenac , Paracetamol & Serratiopeptidase Tablets | Each Film coated tablets contains Aceclofenac Paracetamol Serratiopeptidase ( As enteric coated Granules eq. to Enzymatic activity 30,000 units) Excipients Approved colour used | IP IP IP | 10 325 15 Q.S. | mg mg mg |
| Aceclofenac & Serratiopeptidase Tablets | Each Film coated tablets contains Aceclofenac Serratiopeptidase ( As enteric coated Granules eq. to Enzymatic activity 30,000 units) Excipients Approved colour used | IP IP | 100 15 Q.S. | mg mg |
| Drotaverin & Paracetamol Tablets | Each film coated tablets contains Drotaverin Hydrochloride Paracetamo lExcipients Approved Colour Used | IP IP | 80 325 Q.S. | mg mg |
| Pregabalin & Nortriptyline Tablets | Each film coated tablet contains Pregabalin Nortriptyline HCl Eq. to Nortriptyline Excipients Colour: Approved Colour used | IP IP | 75 10 Q.S. | mg mg |
| Lactic acid Bacillus Tablets | Each uncoated Tablet contains: lactic acid bacillus excipients | 100 Q.S. | Million spores | |
| Calcium Citrate , Magnesium Hydroxide , Zinc Sulphate Monohydrate & Cholecalciferol Tablets | Each uncoated tablet contains Calcium Citrate Magnesium HydroxideEq.to Elemental Magnesium Zinc Sulphate Monohydrate Eq.to Elemental Zinc Cholecalciferol Excipients | USP IP IP IP | 1000 4 4 200 Q.S. | mg mg mg IU |
| Gliclazide & Metformin Tablets | Each uncoated tablet contains Gliclazide Metformin Hydrochloride Excipients | IP IP | 80 500 Q.S. | mg mg |
| Ranitidine Hydrochloride & Domperidone tablets | Each film coated tablet contains Ranitidine Hydrochloride Eq. to Ranitidine Domperidone Excipients Approved Colour Used | IP IP | 150 10 Q.S. | mg mg |
| Trypsin Chymotrypsin Tablets | Each enteric coated tablet contains Trypsin Chymotrypsin (100000 armour units enzymatic activity supplied by a purified concentrate which has specific Trypsin and Chymotrypsin activity in a ratio of apx. 6:1) excipientsApproved colour used | 100000 Q.S. | A.U. |
Capsule
| GENERIC NAME | COMPOSITION | SPEC. | QTY | UNIT |
|---|---|---|---|---|
| Rabeprazole Sodium (EC) & Levosulpiride (SR) Capsule | Each hard gelatin capsule contains Rabeprazole Sodium as (enteric coated pellets) Levosulpiride ( as sustained release pellets) Excipients Approved colour used in capsule shell | IP IP | 20 75 q.s | mg mg |
| Cephalexin Capsules IP 500 mg | Each hard gelatin capsule contains Cephalexin eq.to anh. Cephalexin Excipients Approved Colour used in capsule shell | IP | 500 Q.S. | mg |
| Omeprazole capsule IP 20 mg | Each hard gelatin capsule contains Omeprazole Excipients approved colour used in capsule shells | IP | 20 Q.S. | mg |
| Amoxycillin Capsules with Lactic Acid Bacillus | Each hard gelatin capsule contains Amoxycillin Trihydrate Eq. to Amoxycillin Lactic Acid Bacillus Excipients Approved colour used in capsule shells | IP | 500 1.66 Q.S. | mg Billion Spores |
| Fluconazole Capsules IP 150 mg | Each hard gelatin capsule contains Fluconazole Excipients Approved colour used in capsule shells | IP | 150 Q.S. | mg |
| Fluconazole Capsules IP 200 mg | Each hard gelatin capsule contains Fluconazole Excipients Approved colour used in capsule shells | IP | 200 Q.S. | mg |
| Oxaceprol Capsules 200 mg | Each hard gelatin capsule contains Oxaceprol Excipients Approved colour used in capsule shells | 200 Q.S. | mg | |
| Racecadotril Capsules IP 100 mg | Each hard gelatin capsule contains Racecadotril Excipients Approved colour used in capsule shells | IP | 100 Q.S. | mg |
| Pre & Probiotic Capsules | Each hard gelatin capsule contains Streptococcus faecalis T-110 JPC Clostridium Butyricum TO-A Bacillus mesentericus TO-A JPC Lactic acid bacillus (lactobacillus sporogenes) Excipients Approved colour used in capsule shells | 30 2 1 50 Q.S | million million million million |
|
| Atorvastatin & Aspirin Capsules | Each hard gelatin capsule contains Aspirin Atorvastatin Calcium Eq. to Atorvastatin (as Granules) Excipients Approved colour used in capsule shells | 70 10 Q.S. | mg mg |
|
| Pantoprazole (EC) & Cinitapride (ER) Capsules | Each hard gelatin capsule contains Pantoprazole Sodium Eq. to Pantoprazole (Enteric Coated tablet) Cinitapride Hydrogen Tartrate (As sustained release Tablets) Excipients Approved colour used in capsule shells | 40 3 Q.S. | mg mg |
|
| Cephalexin Capsules IP 250 mg | Each hard gelatin capsule contains Each hard gelatin capsule contains Acebrophylline Excipients Approved colour used in capsule shells | IP | 250 Q.S. | mg |
| Acebrophylline Capsules | Each hard gelatin capsule contains Acebrophylline Excipients Approved colour used in capsule shells | 100 Q.S. | mg | |
| Clindamycin Hydrochloride Capsules IP 150 mg | Each hard gelatin capsule contains Clindamycin Hydrochloride Eq. to Clindamycin Excipients Approved colour used in capsule shells | IP | 150 Q.S. | mg |
| Clindamycin Hydrochloride Capsules IP 300 mg | Each hard gelatin capsule contains Clindamycin Hydrochloride Eq. to Clindamycin Excipients Approved colour used in capsule shells | IP | 300 Q.S. | mg |
| Diacerein Capsules IP 50 mg | Each hard gelatin capsule contains Diacerein Excipients Approved colour used in capsule shells | IP | 50 Q.S. | mg |
| Chloramphenicol Capsule 250 mg | Each hard gelatin capsule contains Chloramphenicol Excipients Approved colour used in capsule shells | IP | 250 Q.S. | mg |
| Silodosin Capsule | Each hard gelatin capsule contains Silodosin Excipients Approved colour used in capsule shells | IP | 8 Q.S. | mg |
| Tamsulosin HCl (MR) Capsules | Each hard gelatin capsule contains Tamsulosin HCl (as MR pellets) Excipients Approved colour used in capsule shells | 400 Q.S. | mg | |
| Gabapentin Capsules | Each hard gelatin capsule contains Gabapentin Excipients Approved colour used in capsule shells | USP | 300 Q.S. | mg |
| Fluoxetine Hydrochloride Capsules IP 20 mg | Each hard gelatin capsule contains Fluoxetine HCl Approved colour used in capsule shells | IP | 20 Q.S. | mg |
| Pre & Probiotic Capsules | Each hard gelatin capsule contains Streptococcus faecalis T-110 JPC Clostridium Butyricum TO-A Bacillus mesentericus TO-A JPC Lactic acid bacillus (lactobacillus sporogenes) Excipients Approved colour used in capsule shell | 60 4 2 100 Q.S. | mg mg mg mg |
|
| Lactobacilllus Acidophilus UBLA-34 , Lactobacillus Sporogenes Unique IS2, Bifidobacterium Longum UBBL-64 , Streptococcus thermophilus UBST-50 ,Fructooligosaccharides Capsules | Each hard gelatin capsule contains Lactobacilllus Acidophilus UBLA-34 Lactobacillus Sporogenes Unique IS2 Bifidobacterium Longum UBBL-64 Streptococcus thermophilus UBST-50 Fructooligosaccharides Excipients Approved colour used in capsule shell | 2.5 2.5 5 5 100 Q.S. | mg mg mg mg mg |
|
| Lactobacilllus Rhamnosus & Lactobacillus Reuteri capsule | Each hard gelatin capsule contains Lactobacilllus rhamnosus GR 1 Lactobacillus Reuteri RC14 Excipients Approved colour used in capsule shells | 1 1 Q.S. | Billion CFU Billion CFU |
|
| Activated Charcoal & Simethicone Capsules | Each hard gelatin capsule contains Activated Charcoal Simethicone Excipients Approved colour used in capsule shells | IP IP | 250 80 Q.S. | mg mg |
| Ampicillin Capsules IP 500 mg | Each hard gelatin capsule contains Ampicillin trihydrate Eq. to Ampicillin Excipients Approved colour used in capsule shell | IP | 500 Q.S. | mg |
| N-Acetyl Cysteine, Ambroxol Hydrochloride Capsules | Each capsule contains N-Acetyl Cysteine Ambroxol Hydrochloride Approved colour used | BP IP | 500 50 Q.S. | mg mg |
| Silodosin & Dutasteride Capsules | Each each hard gelatin Capsules contains Silodosin Dutasteride Excipients Approved colour used in capsule shell | IP IP | 8 0.5 Q.S. | mg mg |
| Prebiotic & Probiotic Capsule | Each capsule contains Skeptococcus Faecalis T-1 10 JPC Clostridium butyricum TO-A Bacillus mesentericus TO-A JPC Lactic acid Bacillus (Lactobacillus sporogenes) Excipients Approved colour used | 60 4 2 100 Q.S. | mg mg mg mg |
|
| Rabeprazole Sodium , Cinitapride Capsules | Each Hard Gelatin Capsule contains Rabeprazole Sodium (as enteric coated tablet) Cinitapride Hydrogen tartrate eq. to Cinitapride (as Sustained Release tablet) Excipients Approved colour used | IP IP | 20 3 Q.S. | mg mg |
| Prebiotic & Probiotic Capsule | Each Hard Gelatin Capsule contains Lactobacillus Acidophilus Lactobacillus Sporogenes Unique BifidoBacterium Longum Streptococcus thermophilus Fructooligosaccharides Excipients Approved colour used | 2.5 2.5 5 5 100 Q.S. | Bn Cfu Bn Cfu Bn Cfu mg |
|
| Calcium Dobesilate Capsule | Each Hard Gelatin Capsule Contains Calcium Dobesilate Monohydrate Eq. to Calcium Dobesilate Excipients Approved colour used in Capsule Shell | IP | 500 Q.S. | mg |
| Dabigatran Etexilate Mesylate Capsule | Each hard gelatin capsule Contains Dabigatran Etexilate Mesylate Eq. to Dabigartan Etexilate Excipients Approved colour used in capsule shell | 110 Q.S. | mg | |
| Flupirtine Maleate Capsule | Each hard gelatin capsule Contains Flupirtine Maleate Excipients Approved colour used in capsule shell | 100 Q.S. | mg | |
| Carbonyl Iron, Folic Acid, Cyanocobalamin & Zinc sulphate Monohydrate Capsules | Each Hard Gelatin Capsule contains Carbonyl IronEq. to Elemental Iron Folic Acid Cyanocobalamin Zinc sulphate Monohydrate Excipients Approved colour used in capsule shell | IP IP IP IP | 100 1.5 15 61.8 Q.S. | mg mg mcg mg |
| Amoxycillin , Dicloxacillin & Lactic Acid Bacillus Capsules | Each Hard Gelatin Capsule contains Amoxycillin Trihydrate Eq. to Amoxycillin Dicloxacillin Sodium Eq. to Dicloxacillin Lactic Acid Bacillus Excipients Approved colour used in capsule shell | IP IP | 250 250 2.5 Q.S. | mg mg mg |
| Rosuvastatin Calcium, Aspirin & Clopidogrel Bisulphate capsules | Each Hard Gelatin Capsule contains Rosuvastatin Calcium eq. to Rosuvastatin ( As Granules) Aspirin (As enteric coated tablets) Clopidogrel Bisulphate eq. to Clopidogrel (As two film coated Tablets) Excipients Approved colour used in capsule Shell | IP IP IP | 10 75 75 Q.S. | mg mg mg |
| Doxycycline Hydrochloride & Lactic Acid Bacillus Capsules | Each Hard gelatin Capsule contains Doxycycline Hydrochloride Eq. to Doxycycline Lactic Acid Bacillus Excipients Approved colour used in capsule shell | IP | 100 60 Q.S. | mg Million Spores |
| Rosuvastatin Calcium & Clopidogrel Bisulphate Capsules | Each Hard Gelatin Capsule contains Rosuvastatin Calcium eq. to Rosuvastatin Clopidogrel Bisulphate eq. to Clopidogrel Excipients Approved colour used in capsule Shell | IP IP | 5 75 Q.S. | mg mg |
| Rosuvastatin Calcium & Clopidogrel Bisulphate Capsules | Each Hard Gelatin Capsule contains Rosuvastatin Calcium eq. to Rosuvastatin Clopidogrel Bisulphate eq. to Clopidogrel Excipients Approved colour used in capsule Shell | IP IP | 10 75 Q.S. | mg mg |
| Rosuvastatin Calcium & Clopidogrel Bisulphate Capsules | Each Hard Gelatin Capsule contains Rosuvastatin Calcium eq. to Rosuvastatin Clopidogrel Bisulphate eq. to Clopidogrel Excipients Approved colour used in capsule Shell | IP IP | 20 75 Q.S. | mg mg |
| Amoxycillin & Lactic Acid Bacillus Capsules | Each hard gelatin capsule contains Amoxycillin Trihydrate Eq. to Amoxycillin Lactic Acid Bacillus Excipients Approved colour used in capsule shell | IP | 500 120 Q.S. | mg Million Spores |
| Amoxycillin & Lactic Acid Bacillus Capsules | Each hard gelatin capsule contains Amoxycillin Trihydrate Eq. to Amoxycillin Lactic Acid Bacillus Excipients Approved colour used in capsule shell | IP | 250 120 | mg Approved colour used in capsule shell |
| Beta Carotene, Multi-vitamin, Minerals, Ginseng & Antioxidant (for Prophylactic use)capsules | Each Hard gelatin capsule contains Ginseng extract Beta Carotene (30%) Vitamin A (as acetate) Thiamine Hydrochloride Riboflavin Pyridoxine Hydrochloride Cyanocobalamin Ascorbic Acid (coated) Vitamin D3 Vitamin E (Acetate) Nicotinamide Calcium Pantothenate Folic Acid Ferrous Fumarate Potassium Sulphate Copper Sulphate Potassium Iodide Manganese Sulphate Monohydrate Magnesium Sulphate Zinc Sulphate Monohydrate Selenium (As Selenium Dioxide) Lactobacillus Sporogenes Excipients Approved colour used in capsule shell | BP BP IP IP IP IP IP IP IP IP IP IP IP IP BP IP USP USP | 48 10 5000 2 3 1 1 50 200 10 25 2 300 30.42 11.1 1.77 0.98 1.54 30.41 2.2 44 60 Q.S. | mg mg IU mg mg mg mcg mg IU mg mg mg mcg mg mg mg mg mg mg mg mcg Million Spores |
| Lycopene, Betacarotene, Zinc Sulphate , Vitamin E & Vitamin C Capsules | Each hard gelatin capsule contains Lycopene (10%) Betacarotene (20%) Zinc sulphate Monohydrate Eq. to Elemental Zinc Vitamin E (As Acetate) Vitamin C Selenium (As sodium Selenate) Excipients Approved colour used | USP USP IP BP IP USP | 5000 10 7.5 25 50 70 Q.S. | mcg mg mg IU mg mcg |
| Multi-vitamin, Minerals, Ginseng & Antioxidant capsules | Each Hard gelatin capsule contains Ginseng extract Vitamin A (as acetate) VITAMIN B1 VITAMIN B2 VITAMIN B6 VITAMIN B12 VITAMIN C (coated) Vitamin D3 Vitamin E (Acetate) Calcium Carbonate eq. to calcium NicotinamideCalcium Carbonate eq. to calcium Calcium Pantothenate Folic Acid Ferrous Furmarate Potassium Sulphate Copper Sulphate Potassium Iodide Manganese Sulphate Monohydrate Magnesium Sulphate Zinc Sulphate Monohydrate Selenium (As Selenium Dioxide) Lactobacillus Sporogenes Excipients Approved colour used in capsule shell | BP IP IP IP IP IP IP IP IP IP IP IP IP IP IP BP IP BP IP USP | 48 2500 2 2 1.5 1 25 200 10 25 10 2 300 30.42 11.1 1.77 0.98 1.54 1.54 2.2 40 60 | mg IU mg mg mg mcg mg IU mg mg mg mg mcg mg m mg mg mg mg mg mcg Million Spores |
| Silodosin Capsule | Each hard gelatin capsule contains Silodosin Excipients Approved colour used in capsule shells | 4 Q.S. | mg | |
| Pregabalin & Methylcobalamin Capsules | Each hard gelatin capsule contains Pregabalin Methylcobalamin ExcipientsApproved colour used | IP IP | 75 750 Q.S. | mg mg |
| Itraconazole Capsules | Each hard gelatin capsule contains Itraconazole Pellets eq. to itraconazole Excipients Approved colour used | BP | 100 Q.S. | mg |
| Itraconazole Capsules | Each hard gelatin capsule contains Itraconazole Pellets eq. to itraconazole ExcipientsApproved colour used | BP | 200 Q.S. | mg |
| Doxycycline Hydrochloride Capsules | Each hard gelatin capsule contains Doxycycline Hydrochloride Eq. to Doxycycline Excipients Approved colour used in capsule shell | IP | 100 Q.S. | mg |
| Amoxycillin Capsules | Each hard gelatin capsule contains Amoxycillin Trihydrate Eq. to Amoxycillin Excipients Approved colour used in capsule shell | IP | 500 Q.S. | mg |
| Pregabalin Capsules | Each hard gelatin capsule contains Pregabalin Pregabalin Approved colour used in capsule shell | IP | 75 Q.S. | mg |
| Rabeprazole Sodium & Itopride hcl capsules | Each Hard Gelatin Capsule contains Rabeprazole Sodium (as enteric coated pellets) Itopride hydrochloride (as sustained release pellets) Excipients Approved colour used in capsule shell | IP IP | 20 150 Q.S. | mg mg |
| Pantoprazole (EC) & Domperidone (ER) Capsules | Each hard gelatin capsule contains Pantoprazole Sodium Eq. to Pantoprazole (Enteric Coated pellets) Domperidone (As sustained release pellets) Excipients Approved colour used in capsule shells | 40 30 Q.S. | mg mg |
|
| Rabeprazole Sodium & Domperidone capsule | Each hard gelatin capsule contains Rabeprazole Sodium (Enteric Coated pellets) Domperidone (As sustained release pellets) Approved Colour used in capsule shell | IP IP | 20 30 Q.S. | mg mg |
| Ampicillin and Dicloxacillin Capsules | Each hard gelatin capsule contains Ampicillin trihydrate Eq. to Ampicillin Dicloxacillin sodium eq.to Dicloxacillin Excipients Approved colour used in capsule shell | IP IP | 250 250 Q.S. | mg mg |
Suspension
| GENERIC NAME | COMPOSITION | SPEC. | QTY | UNIT |
|---|---|---|---|---|
| Sucralfate Suspension | Each 10 ml contains Sucralfate Excipients Excipients | IP | 1 Q.S. | GM |
| Albendazole & Ivermectin Suspension | Each 5 ml contains Albendazole Ivermectin In a flavoured syrupy base Approved colour used | IP IP | 200 1.5 | mg |
| Aluminium Hydroxide, Magnesium Hydroxide & Simethicone Suspension | Each 5 ml contains Dried Aluminium hydroxide Gel Magnesium Hydroxide Simethicone Excipients Approved Colour used | IP IP IP | 250 250 50 Q.S. | mg mg mg |
| Clarithromycin Suspension | Each 5 ml contains Clarithromycin Excipients Colour: approved colour used | USP | 125 Q.S. | mg |
| Clarithromycin Suspension | Each 5 ml contains Clarithromycin Excipients Colour: approved colour used | USP | 250 Q.S. | mg |
| Fexofenadine hydrochloride Suspension | Each 5 ml contains Fexofenadine Hydrochloride Approved Colour used | IP | 30 | mg |
| Levofloxacin & Ornidazole suspension | Each 5 ml contains Levofloxacin Hemihydrate eq. to Levofloxacin Ornidazole Excipients Approved Colour used | IP IP | 125 125 Q.S. | mg mg |
| Mefenamic Acid 100 mg & Paracetamol 250 mg Suspension | Each 5 ml contains Mefenamic Acid Paracetamol Excipients Approved Colour Used | IP IP | 100 250 Q.S. | mg mg |
| Aceclofenac & Paracetamol Suspension | Each 5 ml contains Aceclofenac Paracetamol Flavoured syrupy base Approved Colour Used | IP IP | 50 125 | mg mg |
| Ofloxacin & Metronidazole Suspension | Each 5 ml contains Ofloxacin Metronidazole Benzoate Eq. to Metronidazole Flavoured syrupy base Approved Colour Used | IP IP | 100 200 | mg mg |
| Levofloxacin Suspension | Each 5 ml contains Levofloxacin Hemihydrate eq. to Levofloxacin Excipients Approved Colour used | IP | 125 Q.S. | mg |
| Paracetamol & Ibuprofen suspension | Each 5 ml contains Ibuprofen Paracetamol flavoured syrupy base Approved Colour used | IP IP | 100 162.5 Q.S. | mg mg |
| Fexofenadine Hydrochloride & Montelucast Sodium oral suspension | Each 5ml contains Fexofenadine Hydrochloride Montelucast sodium Eq. to Montelucast In a flavoured syrupy base Approved colour used | IP IP | 60 4 Q.S. | mg mg |
| Rifaximin Oral Suspension | Each 5 ml Suspension contains Rifaximin In a flavoured syrupy base Approved colour used | BP | 100 | mg |
| Sucralfate, Oxetacaine Suspension | Each 10 ml contains Sucralfate Oxetacaine Excipients Approved colour used | IP BP | 1 20 Q.S. | gm mg |
| Albendazole Suspension | Each 5 ml contains Albendazole With Flavoured syrupy base Approved colour used | 200 500 | mg mg |
|
| Bacillus calusii spores suspension (2billion/5ml vial) | Each vial of oral suspension contains spores of Bacillus clausii Purified Water | 2 | Billion Spores | |
| Milk of Magnesia, Liquid Paraffin & Sodium Picosulphate Suspension | Each 5 ml contains Milk of Magnesia Liquid Paraffin Sodium Picosulphate In Flavoured Syrupy base Approved colour used | IP IP BP | 3.75 1.25 3.33 Q.S. | ml ml mg |
| Paracetamol , Chlorpheniramine Maleate & Phenylepherine Hcl Suspension | Each 5 ml Contains Paracetamol Chlorpheniramine Maleate Phenylepherine Hcl In a flavoured syrupy Base Approved color used | IP IP | 250 2 5 Q.S. | mg mg mg |
| Nitazoxanide Oral Suspension | Each 5 ml contains: Nitazoxanide In Flavoured syrupy base Approved colour used | 100 Q.S. | mg | |
| Ofloxacin , Metronidazole & Simethicone Suspension | Each 5 ml Contains Ofloxacin Metronidazole Benzoate Eq. to Metronidazole Simethicone In Flavoured Syrupy Base | IP IP IP | 50 120 10 Q.S. | mg mg mg |
| Sodium Valproate Oral Solution I.P | Each 5 ml Contains Sodium valproate In Flavoured Syrupy Base Approved colors used | IP | 200 Q.S. | mg |
| Ursodeoxycholic Acid Suspension 125 mg/5ml | Each 5 ml Contains Ursodeoxycholic Acid In Flavoured Syrupy Base Approved colors used | IP | 125 Q.S. | mg |
| Ursodeoxycholic Acid Suspension 250 mg/5ml | Each 5 ml Contains Ursodeoxycholic Acid In Flavoured Syrupy Base | IP | 250 Q.S. | mg |
| Ofloxacin & Racecadotril Suspension | Each 5 ml contains Ofloxacin Racecadotril In Flavoured syrupy base Approved colour used | IP IP | 50 15 Q.S. | mg mg |
| Paracetamol, Phenylephrine HCl, Chlorpheniramine, Sodium citrate & menthol Suspension | Each 5 ml contains Paracetamol Phenylephrine HCl Chlorpheniramine Sodium citrate Menthol In flavoured Syrupy base Approved colour used | IP IP IP IP IP | 125 5 0.5 60 1 Q.S. | mg mg mg mg mg |
| Paracetamol, Chlorpheniramine maleate,Phenylephrine HCl, Sodium citrate & menthol Suspension | Each 5 ml contains Paracetamol Chlorpheniramine Maleate Phenylephrine HCl Sodium Citrate Menthol In flavoured Syrupy base Approved colour used | IP IP IP IP IP | 250 2 5 60 1 Q.S. | mg mg mg mg mg |
| Paracetamol suspension IP | Each 5 ml contains Paracetamol flavoured syrupy base Approved Colour used Colour : approved colour used | IP | 250 Q.S. | mg |
| Paracetamol, Phenylephrine HCl, Chlorpheniramine maleate, Sodium citrate & menthol Suspension | Each 5 ml contains Paracetamol Phenylephrine HCl chlorpheniramine maleate Sodium citrate menthol In flavoured Syrupy base Approved colour used | IP IP IP IP IP | 250 5 2 60 1 Q.S. | mg mg mg mg mg |
| Deflazacort oral suspension | Each 5 ml contains Deflazacort flavoured syrupy base Each uncoated tablet contains | 6 | mg | |
| Ferrous Ascorbate & Folic acid suspension | Each 5 ml contains Ferrous Ascorbate Equivalent to elemental Iron Folic acid In flavored syrupy base Approved colour used | IP | 30 550 Q.S. | mg mg |
| Mefenamic Acid 50mg & Paracetamol 125 mg Suspension | Each 5 ml contains Mefenamic Acid Paracetamol Excipients Approved Colour Used | IP IP | 50 125 Q.S. | mg mg |
Syrup
| GENERIC NAME | COMPOSITION | SPEC. | QTY | UNIT |
|---|---|---|---|---|
| Citicoline Sodium & Piracetam Syrup | Each 5 ml contains Citicoline Sodium Eq. to Citicoline Piracetam In a flavoured syrupy base Approved colour used | IP IP | 500 400 Q.S. | mg mg |
| Acebrophylline Syrup 10 mg | Each ml contains Acebrophylline In a flavoured syrupy base Approved colour used | 10 | mg | |
| Acebrophylline, Guaphenesin & Terbutaline Syrup | Each 5 ml contains Acebrophylline Guaphenesin Terbutaline Sulphate In a flavoured syrupy base Approved colour used | IP IP | 50 50 1.25 | mg mg |
| Ambroxol Hydrochloride, Levosalbutamol & Guaiphenesin Syrup | Each 5 ml contains Ambroxol Hydrochloride Levosalbutamol Sulphate eq. to Levosalbutamol Guaiphenesin flavoured syrupy base Colour: Approved Colour used | IP IP IP | 30 1 50 | mg mg mg |
| Bromhexine HCL, Guaiphenesin, Terbutaline & Menthol Syrup | Each 5 ml contains Bromhexine Hcl Guaiphenesin Terbutaline sulphate Menthol flavoured syrupy base Approved Colours used | IP IP IP | 4 50 1.25 0.5 | mg mg mg |
| Cetirizine & Ambroxol Syrup | Each 5 ml contains Cetirizine hydrochloride Ambroxol hydrochloride flavoured syrupy base Approved Colours used | IP IP | 10 30 | mg mg |
| Citicoline Sodium Syrup | Each 5 ml contains Citicoline Sodium eq.to Citicoline flavoured syrupy base Approved Colours used | IP | 500 | mg |
| Cyproheptadine syrup | Each 5 ml contains Cyproheptadine hydrochloride eq.to anh. Cyproheptadine Excipients Approved Colour used | IP | 2 Q.S. | mg |
| Cyproheptadine, Tricholine Citrate & Sorbitol | Each 5 ml contains Cyproheptadine hydrochloride eq.to anh. Cyproheptadine Tricholine Citrate Sorbitol solution 70% flavoured syrupy base Approved Colour used | IP | 2 275 Q.S. | mg mg |
| Desloratadine, Ambroxol HCl,Guaiphenesin and Menthol Syrup | Each 5 ml contains Desloratadine Ambroxol HCl Guaiphenesin Menthol flavoured syrupy base | IP IP IP | 2.5 30 50 1 | mg mg mg mg |
| Bromhexine HCL, Guaiphenesin, Terbutaline & Menthol Syrup | Each 10 ml contains Bromhexine HCl Guaiphenesin Terbutaline sulphate Menthol flavoured syrupy base | IP IP IP | 8 100 2.5 5 | mg mg mg mg |
| Hydroxyzine Hydrochloride Syrup | Each 5 ml contains Hydroxyzine Hydrochloride Flavoured syrupy base Approved Colour used | USP | 10 | mg |
| Levetiracetam oral solution IP | Each ml contains Levetiracetam Flavoured syrupy base Approved Colour used | IP | 100 | mg |
| Levocetirizine & Ambroxol HCl Syrup | Each 5 ml contains Levocetirizine Dihydrochloride Ambroxol Hydrochloride Flavoured syrupy base Approved Colour used | IP IP | 2.5 30 | mg mg |
| Zinc Gluconate syrup | Each 5ml contains Zinc gluconate eq.to elemental zinc In flavoured syrupy base Approved Colour used | USP | 20 | mg |
| Levocetirizine & Montelukast Sodium syrup | Each 5 ml contains Levocetirizine Dihydrochloride Montelukast Sodium eq. to Montelukast In a flavoured syrupy base Approved colour used | IP IP | 2.5 4 | mg mg |
| Ambroxol Hydrochloride, Levosalbutamol & Guaiphenesin Syrup | Each 5 ml contains Ambroxol Hydrochloride Ambroxol Hydrochloride Guaiphenesin flavoured syrupy base | IP IP IP | 15 0.5 50 Q.S. | mg mg mg |
| Cetirizine Hydrochloride syrup | Each 5 ml Contains Cetirizine hydrochloride In a flavoured syrupy base Approved colour used | IP | 5 Q.S. | mg |
| Sodium Picosulphate BP Syrup | Each 5 ml Contains Sodium Picosulphate In a flavoured syrupy base Approved colour used | BP | 5 | mg |
| Tricholine Citrate Syrup | Each 10 ml contains Tricholine Citrate In flavored syrupy base Approved colour used | 500 Q.S. | mg | |
| Prednisolone Sodium Phosphate Syrup | Each 5 ml contains Prednisolone Sodium Phosphate Eq. to Prednisolone In a Flavoured Syrupy Base Approved Colour Used | IP | 5 Q.S. | mg |
| Piracetam Syrup | Each 5 ml contains Piracetam In Flavoured syrupy base Approved colour used | IP | 500 Q.S. | mg |
| Ambroxol , Terbutaline, Guaiphenesin & Menthol Syrup | Each 5 ml contains Ambroxol Hydrochloride Terbutaline Sulphate Guaiphenesin Menthol In Flavoured syrupy base Approved colour used | IP IP IP IP | 15 1.25 50 2.5 Q.S. | mg mg mg mg |
| Diphenhydramine HCl , Ammonium Chloride , Sodium Citrate & Menthol Syrup | Each 5 ml contains Diphenhydramine HCl Ammonium Chloride Sodium Citrate Menthol In Flavoured syrupy base Approved colour used | IP IP IP IP | 14.08 138 57.03 1.14 Q.S. | mg mg mg mg |
| Paracetamol, Phenylephrine HCl & Chlorpheniramine Maleate Syrup | Each 5 ml contains Paracetamol Phenylephrine HCl Chlorpheniramine Maleate In Flavoured syrupy base Approved colour used | IP IP IP | 125 2.5 1 Q.S. | mg mg mg |
| Disodium hydrogen citrate Syrup | Each 5 ml contains Disodium hydrogen citrate In Flavoured Syrupy base Approved colour used | B.P | 1.53 Q.S. | gm |
| Terbutaline Sulphate , Bromhexine Hydrochloride, Guaiphenesin & Menthol Syrup | Each 5 ml Contains Terbutaline Sulphate Bromhexine Hydrochloride Guaiphenesin Menthol In a flavoured syrupy Base Approved colour used | IP IP IP IP | 2.5 8 100 2 Q.S. | mg mg mg mg |
| Carbonyl Iron, Folic Acid, Cyanocobalamin & Zinc Syrup | Each 5 ml contains Carbonyl Iron Eq. to Elemental Iron Folic Acid Cyanocobalamin Elemental Zinc (As Zinc Gluconate) In flavoured syrupy base Approved colour used | IP IP IP IP | 50 500 7.5 5 Q..S. | mg mcg mcg mg |
| Promethazine Hydrochloride Syrup | Each 5 ml (One Tea spoon full ) contains Promethazine Hydrochloride In Flavoured Syrupy Base Approved colour used | IP | 5 Q.S. | mg |
| Potassium Citrate, Magnesium Citrate and Pyridoxine Hydrochloride Syrup | Each 5 ml contains Potassium Citrate Magnesium Citrate Pyridoxine Hydrochloride In Flavoured sorbitol (70%) base Approved colour used | IP USP IP | 1100 375 20 Q.S. | mg mg mg |
| L-Lysine Hydrochloride, Pyridoxine HCl ,Niacinamide , Choline Dihydrogen Citrate,Cyanocobalamin, Sorbitol Solution (70%) non Crystallizing syrup | Each 5 ml contains L-Lysine Hydrochloride Pyridoxine Hydochloride Niacinamide Choline Dihydrogen Citrate Cyanocobalamin Sorbitol solution (70%) non Crystallizing Flavoured syrupy base Approved Colour used | USP IP IP IP IP | 375 1 25 87.5 3 1.5 | mg mg mg mg mcg gm |
| Cetirizine Hydrochloride & Ambroxol Hydrochloride Syrup | Each 5 ml contains Cetirizine hydrochloride Ambroxol hydrochloride flavoured syrupy base Approved Colours used | IP IP | 2.5 15 Q.S. | mg mg |
| zinc, B-Complex & L-Lysine syrup | Each 5 ml contains Zinc sulphate Vitamin B1 Vitamin B2 Vitamin B6 Methylcobalamin Niacinamide L-Lysine Monohydrate Flavoured syrupy base Approved Colour used | IP IP IP IP IP IP USP | 2 1.5 1 0.5 2 15 25 | mg mg mg mg mcg mg mg |
| Diphenhydramine HCl , Ammonium Chloride , Sodium Citrate, Guaiphenesin & Menthol Syrup | Each 5 ml contains Diphenhydramine HCl Ammonium Chloride Sodium Citrate Guaiphenesin MentholIn Flavoured syrupy base Approved colour used | IP IP IP IP IP | 10 60 70 50 1 | mg mg mg mg mg |
| Iron (III) Hydroxide Polymaltose complex & Folic acid syrup | Each 15 ml contains Iron (III) Hydroxide Polymaltose complex Eq. to Elemental Iron Folic acid In Flavoured syrupy base Approved Colour Used | IP IP | 50 0.5 Q.S. | mg mg |
| Lycopene, Pyridoxine HCL, Foilc acid, Vitamin B12 ,copper Sulphate,selenium, Zinc Sulphate Manganese Sulphate & Potassium iodide syrup | Each 10 ml contains Lycopene 10% Pyridoxine HCl Foilc acid Vitamin B12 Copper Sulphate Pentahydrate eq. to Copper Sodium Selenite Pentahydrate eq.to Selenium Zinc Sulphate Monohydrate eq. to zinc Manganese Sulphate eq. To Manganese Potassium iodide eq. to iodide In Flavoured syrupy base Approved colour used | USP IP IP IP BP BP IP USP IP | 1000 1.5 500 5 300 35 2 2 100 Q.S. | mcg mg mcg mcg mcg mg mg mcg |
| Zinc Sulphate .Vitamin B1,Vitamin B2,Vitamin B6 Methylcobalamin, Niacinamide & L-Lysine hydrochloride syrup | Each 5ml contains L-Lysine hydrochloride Methylcobalamin Niacinamide Zinc Sulphate Vitamin B1 Vitamin B2 Vitamin B6 In flavoured Syrupy base Approved colour used | USP IP IP IP IP IP IP | 25 2 15 2 1.5 1 0.5 | mg mg mg mg mg mg mg |
| Ondansetron syrup 2mg | Each 5 ml contains Ondansetron hydrochloride eq to Ondansetron Excipients Approved colour used | IP | 2 Q.S. | mg |
Oral Solution
| GENERIC NAME | COMPOSITION | SPEC. | QTY | UNIT |
|---|---|---|---|---|
| Vitamin D3 oral solution 60000 I.U. | Each 5 ml contains Cholecalciferol ( In nano droplet form) In flavored syrupy base Approved colour used | IP | 60000 Q.S. | I.U. |
Drops
| GENERIC NAME | COMPOSITION | SPEC. | QTY | UNIT |
|---|---|---|---|---|
| Ferrous Ascorbate & Folic acid Drops | Each ml ( Approx. 20 drops) contains Ferrous Ascorbate Equivalent to elemental Iron Folic acid In flavored syrupy base Approved colour used | IP | 10 100 Q.S. | mg mg |
| Cyproheptadine Hydrochloride & Tricholine Citrate Drops | Each ml ( Apx. 20 drops) contains Cyproheptadine Hydrochloride Tricholine Citrate Sorbitol 70 % (non crystallizing ) In flavored syrupy base Approved colour used | IP IP | 1.5 5.5 Q.S. | mg mg |
| Vitamin D3 (Cholecalciferol ) Drops | Each ml contains Vitamin D3 (Cholecalciferol ) In flavored syrupy base Approved colour used | IP | 800 Q.S. | I.U |
| Vitamin D3 (Cholecalciferol ) Drops | Each ml contains Vitamin D3 (Cholecalciferol ) In flavored syrupy base Approved colour used | IP | 400 Q.S. | I.U |
| Dill oil ,Fennel Oil with Simethicone Drops | Each ml contains Simethicone emulsion Equivalent to simethicone Dill oil Fennel Oil Sucrose base | USP BP USP | 40 0.005 0.007 Q.S. | mg ml ml |
| Diastase & Pepsin drops | Each ml ( Appox 20 drops) contains Diastase (1:1200) (Fungal diastase derived from aspergillus oryzae) Digest not less than 40 gm of cooked starch Pepsin (1:3000) Digest not less than 15gm of coagulated egg albumin Excipients Approved colour used | IP IP | 33.33 5 Q.S. | mg mg |
| Dicyclomine HCL & Dimethicone drops | Each ml contains Dicyclomine Hydrochloride Activated Dimethicone In flavored syrupy base Approved colour used | IP IP | 10 40 | mg mg |
| Ambroxol HCl , Terbutaline Sulphate & Guaiphenesin Drops | Each ml (Approx. 20 Drops) contains Ambroxol Hydrochloride Terbutaline Sulphate Guaiphenesin In Flavoured syrupy base Approved colour used | IP IP IP | 7.5 0.25 12.5 Q.S. | mg mg mg |
| Ambroxol Hydrochloride, Levosalbutamol & Guaiphenesin Drops | Each 1 ml contains Ambroxol Hydrochloride Levosalbutamol Sulphate Eqv. To Levosalbutamol Guaiphenesin In Flavoured Syrupy base Approved colour used | IP IP IP | 7.5 0.25 12.5 Q.S. | mg mg mg |
| Phenylephrine Hydrochloride & Chlorpheniramine Maleate drops | Each ml Contains Phenylephrine Hydrochloride Chlorpheniramine Maleate In Flavoured syrupy base Approved colour used | IP IP | 5 2 Q.S. | mg mg |
Oral Suspension
| GENERIC NAME | COMPOSITION | SPEC. | QTY | UNIT |
|---|---|---|---|---|
| Cefixime Oral Suspension IP 25 mg/ ml | Each ml of reconstituted suspension contains Cefixime (as Trihydrate) Eq. to anhydrous Cefixime Approved colour used | IP | 25 | mg |
| Amoxycillin & Clavulanic Acid oral suspension | Each 5 ml of Reconstituted Suspension Contains Amoxycillin Trihydrate Amoxycillin Trihydrate Potassium Clavulanate Diluted Eq. to Clavulanic Acid Excipients | IP IP | 400 57 Q.S. | mg mg |
| Linezolid Oral Suspension | Each 5ml of reconstituted oral suspension contains Linezolid Excipients | IP | 100 Q.S. | mg |
| Calcium Carbonate + Vitamin D3 oral Suspension | Each 5 ml of oral suspension contains Calcium Carbonate eq to elemental calcium Vitamin D3 Excipients | IP IP | 625 250 125 Q..S. | mg mg IU |
| Diastase & Pepsin Oral Suspension | Each 10 ml of reconstituted suspension contains Diastase (1:1200) (Fungal Diastase derived from aspergillus oryzae digests not less than 60gms of cooked starch Pepsin Excipients Approved colour used | IP IP | 50 10 Q.S. | mg mg |
| Ofloxacin oral suspension IP | Each 5 ml contains Ofloxacin Excipients Approved colour used | IP | 100 Q.S. | mg |
| Cefuroxime Axetil Oral Suspension IP | Each 5ml reconstituted suspension contains Cefuroxime Axetil eq. to Cefuroxime (anhydrous) In flavoured bases Approved colour used | IP | 125 Q.S. | mg |
| Colistin Sulphate oral suspension I.P | Each 5 ml of reconstituted suspension contains Colistin Sulphate Eq. to Colistin Approved colour used | IP | 12.5 | mg |
| Cefpodoxime Proxetil oral suspension I.P | Each 5 ml of Reconstituted Suspension Contains Cefpodoxime Proxetil Eq. to Cefpodoxime Excipients Approved colour used | IP | 100 Q.S. | mg |
| Cefixime & Lactic Acid bacillus Oral Suspension | Each 5 ml of Reconstituted Suspension Contains Cefixime Trihydrate Eq. to Cefixime Anhydrous Lactic Acid bacillus Excipients In flavoured syrupy base | IP | 100 60 Q.S. | mg Million Spores |
| Cefixime Oral Suspension IP | Each 5ml of reconstituted suspension contains Cefixime (as Trihydrate) Eq. to anhydrous Cefixime Approved colour used | IP | 50 | mg |
| Magaldrate & Simethicone suspension | Each 5 ml contains Magaldrate Simethicone emulsion eq. to simethicone Excipients Approved Colour used | IP IP | 400 20 Q.S. | mg mg |
| Paracetamol suspension IP | Each 5 ml contains Paracetamol Paracetamol Approved Colour used | IP | 125 Q.S. | mg |
| Ofloxacin oral suspension IP | Each 5 ml contains Ofloxacin Excipients Approved colour used | IP | 50 Q.S. | mg |
Dry Syrup
| GENERIC NAME | COMPOSITION | SPEC. | QTY | UNIT |
|---|---|---|---|---|
| Cefixime, Potassium Clavulanate dry syrup | Each 5 ml of Reconstituted Suspension Contains Cefixime Trihydrate Eq. to Cefixime Anhydrous Potassium Clavulanate Diluted Eq. to Clavulanic Acid Excipients Approved colours used | IP IP | 50 31.25 Q.S. | mg mg |
| Cefixime Trihydrate & Ofloxacin dry syrup | Each 5 ml of Reconstituted Suspension Contains Cefixime Trihydrate Eq. to Cefixime Anhydrous Ofloxacin Excipients Aprroved colour used | IP IP | 50 50 Q.S. | mg mg |
| Cefpodoxime & Clavulanic Acid Dry Syrup | Each 5 ml of Reconstituted Suspension Contains Cefpodoxime Proxetil Eq. to Cefpodoxime Potassium Clavulanate Diluted Eq. to Clavulanic Acid Excipients | IP IP | 50 31.25 Q.S. | mg mg |
| Cefpodoxime & Potassium Clavulanic Acid Dry Syrup | Each 5 ml of Reconstituted Suspension Contains Cefpodoxime Proxetil Eq. to Cefpodoxime Potassium Clavulanate Diluted Eq. to Clavulanic Acid Excipients | IP | 100 62.5 | mg mg |
| Amoxycillin, Potassium Clavulanate & Lactic Acid Bacillus Dry Syrup | Each 5 ml contains Amoxycillin Trihydrate Eq. to Amoxycillin Potassium Clavulanate Lactic Acid Bacillus In flavoured Syrupy base Approved colour used | IP | 250 62.5 120 Q.S. | mg mg mg |
Solution
| GENERIC NAME | COMPOSITION | SPEC. | QTY | UNIT |
|---|---|---|---|---|
| Lactulose Solution | Each 5 ml contains Lactulose As Lactulose concentrate in a flavoured aqueous Base | USP | 3.35 | gm |
Oral Liquid
| GENERIC NAME | COMPOSITION | SPEC. | QTY | UNIT |
|---|---|---|---|---|
| Ferric Ammonium Citrate , Folic Acid, Cyanocobalamin, Manganese Sulphate & Cupric Sulphate oral Liquid | Each 15 ml Contains Ferric Ammonium Citrate eq. to elemental Iron Folic Acid Cyanocobalamin Manganese Sulphate Cupric Sulphate In Flavoured Syrupy base Approved colour used | IP IP IP IP IP | 160 32.8 0.5 7.5 30 30 Q.S. | mg mg mg mcg mcg mcg |
| Ferric Ammonium Citrate, Protein, Cyanocobalamin, Folic Acid oral liquid | Each 5 ml contains Ferric Ammonium Citrate eq. to Elemental Iron Protein Cyanocobalamin Folic Acid Excipients Approved colour used | IP IP IP IP | 50 10.25 0.333 2.5 200 Q.S. | mg mg mg mg mg |
